

<!DOCTYPE html>
<!--[if IE 8]><html class="no-js lt-ie9" lang="en" > <![endif]-->
<!--[if gt IE 8]><!--> <html class="no-js" lang="en" > <!--<![endif]-->
<head>
  <meta charset="utf-8">
  
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  
  <title>CPSR superpanel (v3.0) &mdash; Cancer Predisposition Sequencing Reporter 0.6.2 documentation</title>
  

  
  
  
  

  
  <script type="text/javascript" src="_static/js/modernizr.min.js"></script>
  
    
      <script type="text/javascript" id="documentation_options" data-url_root="./" src="_static/documentation_options.js"></script>
        <script src="_static/jquery.js"></script>
        <script src="_static/underscore.js"></script>
        <script src="_static/doctools.js"></script>
        <script src="_static/language_data.js"></script>
    
    <script type="text/javascript" src="_static/js/theme.js"></script>

    

  
  <link rel="stylesheet" href="_static/css/theme.css" type="text/css" />
  <link rel="stylesheet" href="_static/pygments.css" type="text/css" />
    <link rel="author" title="About these documents" href="about.html" />
    <link rel="index" title="Index" href="genindex.html" />
    <link rel="search" title="Search" href="search.html" />
    <link rel="next" title="Input" href="input.html" />
    <link rel="prev" title="CPSR annotation resources" href="annotation_resources.html" /> 
</head>

<body class="wy-body-for-nav">

   
  <div class="wy-grid-for-nav">
    
    <nav data-toggle="wy-nav-shift" class="wy-nav-side">
      <div class="wy-side-scroll">
        <div class="wy-side-nav-search" >
          

          
            <a href="index.html" class="icon icon-home"> Cancer Predisposition Sequencing Reporter
          

          
          </a>

          
            
            
              <div class="version">
                0.6.2
              </div>
            
          

          
<div role="search">
  <form id="rtd-search-form" class="wy-form" action="search.html" method="get">
    <input type="text" name="q" placeholder="Search docs" />
    <input type="hidden" name="check_keywords" value="yes" />
    <input type="hidden" name="area" value="default" />
  </form>
</div>

          
        </div>

        <div class="wy-menu wy-menu-vertical" data-spy="affix" role="navigation" aria-label="main navigation">
          
            
            
              
            
            
              <p class="caption"><span class="caption-text">Table of Contents</span></p>
<ul class="current">
<li class="toctree-l1"><a class="reference internal" href="about.html">About</a></li>
<li class="toctree-l1"><a class="reference internal" href="getting_started.html">Getting started</a></li>
<li class="toctree-l1"><a class="reference internal" href="annotation_resources.html">CPSR annotation resources</a></li>
<li class="toctree-l1 current"><a class="current reference internal" href="#">CPSR superpanel (v3.0)</a></li>
<li class="toctree-l1"><a class="reference internal" href="input.html">Input</a></li>
<li class="toctree-l1"><a class="reference internal" href="output.html">Output</a></li>
<li class="toctree-l1"><a class="reference internal" href="variant_classification.html">Variant classification (ACMG/AMP)</a></li>
<li class="toctree-l1"><a class="reference internal" href="CHANGELOG.html">CHANGELOG</a></li>
</ul>

            
          
        </div>
      </div>
    </nav>

    <section data-toggle="wy-nav-shift" class="wy-nav-content-wrap">

      
      <nav class="wy-nav-top" aria-label="top navigation">
        
          <i data-toggle="wy-nav-top" class="fa fa-bars"></i>
          <a href="index.html">Cancer Predisposition Sequencing Reporter</a>
        
      </nav>


      <div class="wy-nav-content">
        
        <div class="rst-content">
        
          















<div role="navigation" aria-label="breadcrumbs navigation">

  <ul class="wy-breadcrumbs">
    
      <li><a href="index.html">Docs</a> &raquo;</li>
        
      <li>CPSR superpanel (v3.0)</li>
    
    
      <li class="wy-breadcrumbs-aside">
        
            
            <a href="_sources/superpanel.rst.txt" rel="nofollow"> View page source</a>
          
        
      </li>
    
  </ul>

  
  <hr/>
</div>
          <div role="main" class="document" itemscope="itemscope" itemtype="http://schema.org/Article">
           <div itemprop="articleBody">
            
  <div class="section" id="cpsr-superpanel-v3-0">
<h1>CPSR superpanel (v3.0)<a class="headerlink" href="#cpsr-superpanel-v3-0" title="Permalink to this headline">¶</a></h1>
<p>We have aggregated data from multiple sources to compile an exploratory
track of <strong>n = 433</strong> genes with associations to cancer
predisposition/cancer syndromes:</p>
<ul class="simple">
<li><p><em>TCGA_PANCAN_18</em> - TCGCA Pancancer germline study - <a class="reference external" href="https://www.ncbi.nlm.nih.gov/pubmed/29625052">Huang et al,
Cell, 2018</a></p></li>
<li><p><em>CGC_94</em> - Curated list - <a class="reference external" href="https://cancer.sanger.ac.uk/census">Cancer Gene Census
(COSMIC)</a> - version 94</p></li>
<li><p><em>NCGC</em> - Expert-curated list from <a class="reference external" href="http://cancergenomics.no">Norwegian Cancer Genomics
Consortium</a></p></li>
<li><p><em>PANEL_APP</em> - knowledge base of virtual gene panels related to human
disorders - all unique genes from 42 panels linked to inherited
cancers and cancer susceptibility</p></li>
<li><p><em>OTHER</em> - Other potential cancer-relevant genes, as contributed by
the CPSR user community</p></li>
</ul>
<p>Data with respect to mechanisms of inheritance (MoI - autosomal
recessive (AR) vs. autosomal dominant (AD) etc.) and whether mechanisms
of disease are associated with loss-of-function (LoF) or
gain-of-function (GoF) were primarily retrieved from <a class="reference external" href="https://www.ncbi.nlm.nih.gov/pubmed/27153395">Maxwell et al., Am
J Hum Genet, 2016</a>, and
<a class="reference external" href="https://panelapp.genomicsengland.co.uk/">Genomics England PanelApp</a></p>
<p>We want to make it explicit that this lis by no means regarded as an
international consensus, but should rather be subject to continuous
update by the international community that carry expertise on genetic
risk factors for cancer.</p>
<p>Do you miss other genes of relevance for cancer predisposition/inherited
tumor syndromes? Please forward a list of gene identifiers, preferably
also with mode of inheritance and literature support to sigven AT
ifi.uio.no, so we can include them in Panel 0.</p>
<p><a class="reference external" href="cpsr_superpanel_0.6.2.xlsx">Download the complete set of CPSR superpanel genes, grch37/grch38
versions (xlsx)</a></p>
<table class="docutils align-default">
<colgroup>
<col style="width: 4%" />
<col style="width: 18%" />
<col style="width: 4%" />
<col style="width: 4%" />
<col style="width: 4%" />
<col style="width: 4%" />
<col style="width: 21%" />
<col style="width: 10%" />
<col style="width: 32%" />
</colgroup>
<thead>
<tr class="row-odd"><th class="head"><p>n
o</p></th>
<th class="head"><p>gene_link</p></th>
<th class="head"><p>e
n
t
r
e
z
g
e
n
e</p></th>
<th class="head"><p>e
n
s
e
m
b
l
_
g
e
n
e
_
i
d</p></th>
<th class="head"><p>m
o
i</p></th>
<th class="head"><p>m
o
d</p></th>
<th class="head"><p>gene_name</p></th>
<th class="head"><p>s
ource</p></th>
<th class="head"><p>ph
enotype_syndrome_term</p></th>
</tr>
</thead>
<tbody>
<tr class="row-even"><td><p>1</p></td>
<td><p>ABCB11</p></td>
<td><p>8
6
4
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
7
3
7
3
4</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>ATP binding
cassette
subfamily B
member 11</p></td>
<td><p>T
CGA_P
ANCAN
_2018</p></td>
<td><p>Crigler-Najjar
syndrome, type II</p></td>
</tr>
<tr class="row-odd"><td><p>2</p></td>
<td><p>ABL1</p></td>
<td><p>2
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
9
7
0
0
7</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>ABL
p
roto-oncogene
1,
non-receptor
tyrosine
kinase</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3</p></td>
<td><p>ABL2</p></td>
<td><p>2
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
3
3
2
2</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>ABL
p
roto-oncogene
2,
non-receptor
tyrosine
kinase</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>4</p></td>
<td><p>ABRAXAS1</p></td>
<td><p>8
4
1
4
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
3
3
2
2</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>abraxas 1,
BRCA1 A
complex
subunit</p></td>
<td><p>NCGC</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>5</p></td>
<td><p>ACD</p></td>
<td><p>6
5
0
5
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
2
9
7
7</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>N
A</p></td>
<td><p>ACD shelterin
complex
subunit and
telomerase
recruitment
factor</p></td>
<td><p>NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>6</p></td>
<td><p>ACTRT1</p></td>
<td><p>1
3
9
7
4
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
3
1
6
5</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>actin related
protein T1</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>7</p></td>
<td><p>ADM</p></td>
<td><p>1
3
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
8
9
2
6</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>a
drenomedullin</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>8</p></td>
<td><p>AIP</p></td>
<td><p>9
0
4
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
0
7
1
1</p></td>
<td><p>A
D</p></td>
<td><p>L
o
F</p></td>
<td><p>aryl
hydrocarbon
receptor
interacting
protein</p></td>
<td><p>NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>9</p></td>
<td><p>AKT1</p></td>
<td><p>2
0
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
2
2
0
8</p></td>
<td><p>A
D</p></td>
<td><p>G
o
F</p></td>
<td><p>AKT
ser
ine/threonine
kinase 1</p></td>
<td><p>NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
0</p></td>
<td><p>ALK</p></td>
<td><p>2
3
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
1
0
9
4</p></td>
<td><p>A
D</p></td>
<td><p>G
o
F</p></td>
<td><p>ALK receptor
tyrosine
kinase</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id1"><span class="problematic" id="id2">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Neuroblastoma</p></td>
</tr>
<tr class="row-even"><td><p>1
1</p></td>
<td><p>AMER1</p></td>
<td><p>1
3
9
2
8
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
4
6
7
5</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>APC membrane
recruitment
protein 1</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
2</p></td>
<td><p>ANKRD26</p></td>
<td><p>2
2
8
5
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
7
8
9
0</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>ankyrin
repeat domain
26</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
3</p></td>
<td><p>APC</p></td>
<td><p>3
2
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
4
9
8
2</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>APC regulator
of WNT
signaling
pathway</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id3"><span class="problematic" id="id4">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Familial multiple
polyposis syndrome;
Familial adenomatous
polyposis 1</p></td>
</tr>
<tr class="row-odd"><td><p>1
4</p></td>
<td><p>APOBEC3B</p></td>
<td><p>9
5
8
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
9
7
5
0</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>a
polipoprotein
B mRNA
editing
enzyme
catalytic
subunit 3B</p></td>
<td><p>C
GC_94</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
5</p></td>
<td><p>AR</p></td>
<td><p>3
6
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
9
0
8
3</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>androgen
receptor</p></td>
<td><p>C
GC_94
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
6</p></td>
<td><p>ARHGEF12</p></td>
<td><p>2
3
3
6
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
9
6
9
1
4</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>Rho guanine
nucleotide
exchange
factor 12</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
7</p></td>
<td><p>ARID1A</p></td>
<td><p>8
2
8
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
7
7
1
3</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>AT-rich
interaction
domain 1A</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
8</p></td>
<td><p>ARID2</p></td>
<td><p>1
9
6
5
2
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
9
0
7
9</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>AT-rich
interaction
domain 2</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
9</p></td>
<td><p>ARID5B</p></td>
<td><p>8
4
1
5
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
5
0
3
4
7</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>AT-rich
interaction
domain 5B</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
0</p></td>
<td><p>ARMC5</p></td>
<td><p>7
9
7
9
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
0
6
9
1</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>armadillo
repeat
containing 5</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
1</p></td>
<td><p>ASXL1</p></td>
<td><p>1
7
1
0
2
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
1
4
5
6</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>ASXL
tr
anscriptional
regulator 1</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
2</p></td>
<td><p>ATM</p></td>
<td><p>4
7
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
9
3
1
1</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>ATM
ser
ine/threonine
kinase</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id5"><span class="problematic" id="id6">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Ataxia-telangiectasia
syndrome</p></td>
</tr>
<tr class="row-even"><td><p>2
3</p></td>
<td><p>ATR</p></td>
<td><p>5
4
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
5
0
5
4</p></td>
<td><p>A
D</p></td>
<td><p>L
o
F</p></td>
<td><p>ATR
ser
ine/threonine
kinase</p></td>
<td><p>CGC
_94,P
<a href="#id7"><span class="problematic" id="id8">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Seckel syndrome;
Cutaneous
telangiectasia and
cancer syndrome,
familial</p></td>
</tr>
<tr class="row-odd"><td><p>2
4</p></td>
<td><p>ATRX</p></td>
<td><p>5
4
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
8
5
2
2
4</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>ATRX
chromatin
remodeler</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
5</p></td>
<td><p>AXIN1</p></td>
<td><p>8
3
1
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
3
1
2
6</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>axin 1</p></td>
<td><p>NCGC</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
6</p></td>
<td><p>AXIN2</p></td>
<td><p>8
3
1
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
8
6
4
6</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>axin 2</p></td>
<td><p>CGC
_94,N
CGC,T
CGA_P
ANCAN
_2018</p></td>
<td><p>O
ligodontia-colorectal
cancer syndrome</p></td>
</tr>
<tr class="row-even"><td><p>2
7</p></td>
<td><p>BAP1</p></td>
<td><p>8
3
1
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
3
9
3
0</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>BRCA1
associated
protein 1</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id9"><span class="problematic" id="id10">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Tumor susceptibility
linked to germline
BAP1 mutations; BAP1
Cancer Syndrome</p></td>
</tr>
<tr class="row-odd"><td><p>2
8</p></td>
<td><p>BARD1</p></td>
<td><p>5
8
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
8
3
7
6</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>BRCA1
associated
RING domain 1</p></td>
<td><p>C
GC_94
,NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
9</p></td>
<td><p>BCL10</p></td>
<td><p>8
9
1
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
2
8
6
7</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>BCL10 immune
signaling
adaptor</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
0</p></td>
<td><p>BCR</p></td>
<td><p>6
1
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
6
7
1
6</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>BCR activator
of RhoGEF and
GTPase</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
1</p></td>
<td><p>BLM</p></td>
<td><p>6
4
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
9
7
2
9
9</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>BLM RecQ like
helicase</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id11"><span class="problematic" id="id12">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Bloom syndrome</p></td>
</tr>
<tr class="row-odd"><td><p>3
2</p></td>
<td><p>BMPR1A</p></td>
<td><p>6
5
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
7
7
7
9</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>bone
morphogenetic
protein
receptor type
1A</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id13"><span class="problematic" id="id14">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Juvenile polyposis
syndrome</p></td>
</tr>
<tr class="row-even"><td><p>3
3</p></td>
<td><p>BRAF</p></td>
<td><p>6
7
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
5
7
7
6
4</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>B-Raf
pr
oto-oncogene,
ser
ine/threonine
kinase</p></td>
<td><p>P
<a href="#id15"><span class="problematic" id="id16">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Noonan syndrome 7;
LEOPARD syndrome 3</p></td>
</tr>
<tr class="row-odd"><td><p>3
4</p></td>
<td><p>BRCA1</p></td>
<td><p>6
7
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
1
2
0
4
8</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>BRCA1 DNA
repair
associated</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id17"><span class="problematic" id="id18">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hereditary breast and
ovarian cancer
syndrome</p></td>
</tr>
<tr class="row-even"><td><p>3
5</p></td>
<td><p>BRCA2</p></td>
<td><p>6
7
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
9
6
1
8</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>BRCA2 DNA
repair
associated</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id19"><span class="problematic" id="id20">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hereditary breast and
ovarian cancer
syndrome; Fanconi
anemia,
complementation group
D1</p></td>
</tr>
<tr class="row-odd"><td><p>3
6</p></td>
<td><p>BRIP1</p></td>
<td><p>8
3
9
9
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
6
4
9
2</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>BRCA1
interacting
helicase 1</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id21"><span class="problematic" id="id22">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Fanconi anemia,
complementation group
J</p></td>
</tr>
<tr class="row-even"><td><p>3
7</p></td>
<td><p>BTK</p></td>
<td><p>6
9
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
1
0
6
7
1</p></td>
<td><p>X
L
R</p></td>
<td><p>N
A</p></td>
<td><p>Bruton
tyrosine
kinase</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
8</p></td>
<td><p>BUB1</p></td>
<td><p>6
9
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
9
6
7
9</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>BUB1 mitotic
checkpoint
ser
ine/threonine
kinase</p></td>
<td><p>NCGC</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
9</p></td>
<td><p>BUB1B</p></td>
<td><p>7
0
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
5
6
9
7
0</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>BUB1 mitotic
checkpoint
ser
ine/threonine
kinase B</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id23"><span class="problematic" id="id24">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Mosaic variegated
aneuploidy syndrome 1</p></td>
</tr>
<tr class="row-odd"><td><p>4
0</p></td>
<td><p>BUB3</p></td>
<td><p>9
1
8
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
5
4
4
7
3</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>BUB3 mitotic
checkpoint
protein</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>4
1</p></td>
<td><p>CAMTA1</p></td>
<td><p>2
3
2
6
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
1
7
3
5</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>calmodulin
binding
transcription
activator 1</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>4
2</p></td>
<td><p>CASP8</p></td>
<td><p>8
4
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
6
4
0
1
2</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>caspase 8</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>4
3</p></td>
<td><p>CASR</p></td>
<td><p>8
4
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
3
6
8
2
8</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>calcium
sensing
receptor</p></td>
<td><p>NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>4
4</p></td>
<td><p>CBFA2T3</p></td>
<td><p>8
6
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
9
9
9
3</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>CBFA2/RUNX1
partner
tr
anscriptional
co-repressor
3</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>4
5</p></td>
<td><p>CBL</p></td>
<td><p>8
6
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
0
3
9
5</p></td>
<td><p>A
D</p></td>
<td><p>L
o
F</p></td>
<td><p>Cbl
p
roto-oncogene</p></td>
<td><p>P
<a href="#id25"><span class="problematic" id="id26">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Noonan syndrome</p></td>
</tr>
<tr class="row-odd"><td><p>4
6</p></td>
<td><p>CDC73</p></td>
<td><p>7
9
5
7
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
4
3
7
1</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>cell division
cycle 73</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id27"><span class="problematic" id="id28">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hyperparathyroidism 2</p></td>
</tr>
<tr class="row-even"><td><p>4
7</p></td>
<td><p>CDH1</p></td>
<td><p>9
9
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
3
9
0
6
8</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>cadherin 1</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id29"><span class="problematic" id="id30">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hereditary diffuse
gastric cancer</p></td>
</tr>
<tr class="row-odd"><td><p>4
8</p></td>
<td><p>CDH10</p></td>
<td><p>1
0
0
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
4
0
7
3
1</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>cadherin 10</p></td>
<td><p>C
GC_94</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>4
9</p></td>
<td><p>CDH11</p></td>
<td><p>1
0
0
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
0
9
3
7</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>cadherin 11</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>5
0</p></td>
<td><p>CDK4</p></td>
<td><p>1
0
1
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
5
4
4
6</p></td>
<td><p>A
D</p></td>
<td><p>G
o
F</p></td>
<td><p>cyclin
dependent
kinase 4</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id31"><span class="problematic" id="id32">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hereditary melanoma;
Cutaneous malignant
melanoma 3</p></td>
</tr>
<tr class="row-even"><td><p>5
1</p></td>
<td><p>CDKN1A</p></td>
<td><p>1
0
2
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
4
7
6
2</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>cyclin
dependent
kinase
inhibitor 1A</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>5
2</p></td>
<td><p>CDKN1B</p></td>
<td><p>1
0
2
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
1
2
7
6</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>cyclin
dependent
kinase
inhibitor 1B</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id33"><span class="problematic" id="id34">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Multiple endocrine
neoplasia, type 4</p></td>
</tr>
<tr class="row-even"><td><p>5
3</p></td>
<td><p>CDKN1C</p></td>
<td><p>1
0
2
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
9
7
5
7</p></td>
<td><p>A
D</p></td>
<td><p>L
o
F</p></td>
<td><p>cyclin
dependent
kinase
inhibitor 1C</p></td>
<td><p>N
CGC,P
<a href="#id35"><span class="problematic" id="id36">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Beckwith-Wiedemann
syndrome</p></td>
</tr>
<tr class="row-odd"><td><p>5
4</p></td>
<td><p>CDKN2A</p></td>
<td><p>1
0
2
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
7
8
8
9</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>cyclin
dependent
kinase
inhibitor 2A</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id37"><span class="problematic" id="id38">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hereditary melanoma</p></td>
</tr>
<tr class="row-even"><td><p>5
5</p></td>
<td><p>CDKN2B</p></td>
<td><p>1
0
3
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
7
8
8
3</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>cyclin
dependent
kinase
inhibitor 2B</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>5
6</p></td>
<td><p>CDKN2C</p></td>
<td><p>1
0
3
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
3
0
8
0</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>cyclin
dependent
kinase
inhibitor 2C</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>5
7</p></td>
<td><p>CEBPA</p></td>
<td><p>1
0
5
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
4
5
8
4
8</p></td>
<td><p>A
D</p></td>
<td><p>L
o
F</p></td>
<td><p>CCAAT
enhancer
binding
protein alpha</p></td>
<td><p>N
CGC,P
<a href="#id39"><span class="problematic" id="id40">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Acute myeloid
leukemia</p></td>
</tr>
<tr class="row-odd"><td><p>5
8</p></td>
<td><p>CEBPE</p></td>
<td><p>1
0
5
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
9
2
0
6
7</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>CCAAT
enhancer
binding
protein
epsilon</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>5
9</p></td>
<td><p>CENPJ</p></td>
<td><p>5
5
8
3
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
5
1
8
4
9</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>centromere
protein J</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>6
0</p></td>
<td><p>CEP57</p></td>
<td><p>9
7
0
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
6
0
3
7</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>centrosomal
protein 57</p></td>
<td><p>NCGC</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>6
1</p></td>
<td><p>CHEK1</p></td>
<td><p>1
1
1
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
9
5
5
4</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>checkpoint
kinase 1</p></td>
<td><p>NCGC</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>6
2</p></td>
<td><p>CHEK2</p></td>
<td><p>1
1
2
0
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
3
7
6
5</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>checkpoint
kinase 2</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id41"><span class="problematic" id="id42">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Familial cancer of
breast</p></td>
</tr>
<tr class="row-even"><td><p>6
3</p></td>
<td><p>CIB1</p></td>
<td><p>1
0
5
1
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
5
0
4
3</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>calcium and
integrin
binding 1</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>6
4</p></td>
<td><p>COL7A1</p></td>
<td><p>1
2
9
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
4
2
7
0</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>collagen type
VII alpha 1
chain</p></td>
<td><p>T
CGA_P
ANCAN
_2018</p></td>
<td><p>Epidermolysis bullosa</p></td>
</tr>
<tr class="row-even"><td><p>6
5</p></td>
<td><p>CREBBP</p></td>
<td><p>1
3
8
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
0
5
3
3
9</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>CREB binding
protein</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>6
6</p></td>
<td><p>CSF3R</p></td>
<td><p>1
4
4
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
9
5
3
5</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>colony
stimulating
factor 3
receptor</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>6
7</p></td>
<td><p>CTC1</p></td>
<td><p>8
0
1
6
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
8
9
7
1</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>CST telomere
replication
complex
component 1</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>6
8</p></td>
<td><p>CTNNA1</p></td>
<td><p>1
4
9
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
4
4
1
1
5</p></td>
<td><p>A
D</p></td>
<td><p>L
o
F</p></td>
<td><p>catenin alpha
1</p></td>
<td><p>NCGC,
OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>6
9</p></td>
<td><p>CTNNB1</p></td>
<td><p>1
4
9
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
8
0
3
6</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>catenin beta
1</p></td>
<td><p>NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>7
0</p></td>
<td><p>CTR9</p></td>
<td><p>9
6
4
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
9
8
7
3
0</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>CTR9 homolog,
Paf1/RNA
polymerase II
complex
component</p></td>
<td><p>P
<a href="#id43"><span class="problematic" id="id44">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>7
1</p></td>
<td><p>CTRC</p></td>
<td><p>1
1
3
3
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
2
4
3
8</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>chymotrypsin
C</p></td>
<td><p>NCGC</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>7
2</p></td>
<td><p>CXCR4</p></td>
<td><p>7
8
5
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
1
9
6
6</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>C-X-C motif
chemokine
receptor 4</p></td>
<td><p>C
GC_94</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>7
3</p></td>
<td><p>CYLD</p></td>
<td><p>1
5
4
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
8
3
7
9
9</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>CYLD lysine
63
d
eubiquitinase</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id45"><span class="problematic" id="id46">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Brooke-Spiegler
syndrome</p></td>
</tr>
<tr class="row-odd"><td><p>7
4</p></td>
<td><p>DDB2</p></td>
<td><p>1
6
4
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
4
5
7
4</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>damage
specific DNA
binding
protein 2</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id47"><span class="problematic" id="id48">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Xeroderma
pigmentosum, group E</p></td>
</tr>
<tr class="row-even"><td><p>7
5</p></td>
<td><p>DDX11</p></td>
<td><p>1
6
6
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
1
3
5
7
3</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>DEAD/H-box
helicase 11</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>7
6</p></td>
<td><p>DDX41</p></td>
<td><p>5
1
4
2
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
3
2
5
8</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>DEAD-box
helicase 41</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>7
7</p></td>
<td><p>DGCR8</p></td>
<td><p>5
4
4
8
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
8
1
9
1</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>DGCR8
m
icroprocessor
complex
subunit</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>7
8</p></td>
<td><p>DHCR7</p></td>
<td><p>1
7
1
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
2
8
9
3</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>7-dehyd
rocholesterol
reductase</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>7
9</p></td>
<td><p>DICER1</p></td>
<td><p>2
3
4
0
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
0
6
9
7</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>dicer 1,
ribonuclease
III</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id49"><span class="problematic" id="id50">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Pleuropulmonary
blastoma;
DICER1-related
pleuropulmonary
blastoma cancer
predisposition
syndrome</p></td>
</tr>
<tr class="row-odd"><td><p>8
0</p></td>
<td><p>DIRAS3</p></td>
<td><p>9
0
7
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
2
5
9
5</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>DIRAS family
GTPase 3</p></td>
<td><p>NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>8
1</p></td>
<td><p>DIS3</p></td>
<td><p>2
2
8
9
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
8
3
5
2
0</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>DIS3 homolog,
exosome
end
oribonuclease
and 3’-5’
ex
oribonuclease</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>8
2</p></td>
<td><p>DIS3L</p></td>
<td><p>1
1
5
7
5
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
6
9
3
8</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>DIS3 like
exosome 3’-5’
ex
oribonuclease</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>8
3</p></td>
<td><p>DIS3L2</p></td>
<td><p>1
2
9
5
6
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
4
5
3
5</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>DIS3 like
3’-5’
ex
oribonuclease
2</p></td>
<td><p>N
CGC,P
<a href="#id51"><span class="problematic" id="id52">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Perlman syndrome</p></td>
</tr>
<tr class="row-odd"><td><p>8
4</p></td>
<td><p>DKC1</p></td>
<td><p>1
7
3
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
0
8
2
6</p></td>
<td><p>N
A</p></td>
<td><p>L
o
F</p></td>
<td><p>dyskerin
pseudouridine
synthase 1</p></td>
<td><p>P
<a href="#id53"><span class="problematic" id="id54">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Dyskeratosis
congenita, X-linked</p></td>
</tr>
<tr class="row-even"><td><p>8
5</p></td>
<td><p>DNAJC21</p></td>
<td><p>1
3
4
2
1
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
8
7
2
4</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>DnaJ heat
shock protein
family
(Hsp40)
member C21</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>8
6</p></td>
<td><p>DOCK8</p></td>
<td><p>8
1
7
0
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
7
0
9
9</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>dedicator of
cytokinesis 8</p></td>
<td><p>P
<a href="#id55"><span class="problematic" id="id56">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hyper-Immunoglobulin
E Syndrome, Autosomal
Recessive</p></td>
</tr>
<tr class="row-even"><td><p>8
7</p></td>
<td><p>DROSHA</p></td>
<td><p>2
9
1
0
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
3
3
6
0</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>drosha
ribonuclease
III</p></td>
<td><p>T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>8
8</p></td>
<td><p>DTX3L</p></td>
<td><p>1
5
1
6
3
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
3
8
4
0</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>deltex E3
ubiquitin
ligase 3L</p></td>
<td><p>NCGC</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>8
9</p></td>
<td><p>EGFR</p></td>
<td><p>1
9
5
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
6
6
4
8</p></td>
<td><p>A
D</p></td>
<td><p>G
o
F</p></td>
<td><p>epidermal
growth factor
receptor</p></td>
<td><p>CGC
_94,N
CGC,T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>9
0</p></td>
<td><p>ELAC2</p></td>
<td><p>6
0
5
2
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
0
6
7
4
4</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>elaC
ribonuclease
Z 2</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>9
1</p></td>
<td><p>ELANE</p></td>
<td><p>1
9
9
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
9
7
5
6
1</p></td>
<td><p>A
D</p></td>
<td><p>L
o
F</p></td>
<td><p>elastase,
neutrophil
expressed</p></td>
<td><p>P
<a href="#id57"><span class="problematic" id="id58">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Neutropenia, severe
congenital 1,
autosomal dominant</p></td>
</tr>
<tr class="row-odd"><td><p>9
2</p></td>
<td><p>ELP1</p></td>
<td><p>8
5
1
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
7
0
0
6
1</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>elongator
acet
yltransferase
complex
subunit 1</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>9
3</p></td>
<td><p>ENG</p></td>
<td><p>2
0
2
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
6
9
9
1</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>endoglin</p></td>
<td><p>ACMG
_SF30
,NCGC
,PANE
L_APP</p></td>
<td><p>Hereditary
hemorrhagic
telangiectasia</p></td>
</tr>
<tr class="row-odd"><td><p>9
4</p></td>
<td><p>EP300</p></td>
<td><p>2
0
3
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
0
3
9
3</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>E1A binding
protein p300</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>9
5</p></td>
<td><p>EPAS1</p></td>
<td><p>2
0
3
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
6
0
1
6</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>endothelial
PAS domain
protein 1</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>9
6</p></td>
<td><p>EPCAM</p></td>
<td><p>4
0
7
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
9
8
8
8</p></td>
<td><p>A
D</p></td>
<td><p>L
o
F</p></td>
<td><p>epithelial
cell adhesion
molecule</p></td>
<td><p>N
CGC,P
<a href="#id59"><span class="problematic" id="id60">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hereditary
nonpolyposis
colorectal cancer
type 8</p></td>
</tr>
<tr class="row-even"><td><p>9
7</p></td>
<td><p>ERBB2</p></td>
<td><p>2
0
6
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
1
7
3
6</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>erb-b2
receptor
tyrosine
kinase 2</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>9
8</p></td>
<td><p>ERBB4</p></td>
<td><p>2
0
6
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
8
5
6
8</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>erb-b2
receptor
tyrosine
kinase 4</p></td>
<td><p>C
GC_94</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>9
9</p></td>
<td><p>ERCC1</p></td>
<td><p>2
0
6
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
1
2
0
6
1</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>ERCC excision
repair 1,
endonuclease
non-catalytic
subunit</p></td>
<td><p>N
CGC,P
<a href="#id61"><span class="problematic" id="id62">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Cere
brooculofacioskeletal
syndrome 4</p></td>
</tr>
<tr class="row-odd"><td><p>1
0
0</p></td>
<td><p>ERCC2</p></td>
<td><p>2
0
6
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
4
8
8
4</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>ERCC excision
repair 2,
TFIIH core
complex
helicase
subunit</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id63"><span class="problematic" id="id64">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Xeroderma
pigmentosum, group D</p></td>
</tr>
<tr class="row-even"><td><p>1
0
1</p></td>
<td><p>ERCC3</p></td>
<td><p>2
0
7
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
3
1
6
1</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>ERCC excision
repair 3,
TFIIH core
complex
helicase
subunit</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id65"><span class="problematic" id="id66">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Xeroderma
pigmentosum,
complementation group
b</p></td>
</tr>
<tr class="row-odd"><td><p>1
0
2</p></td>
<td><p>ERCC4</p></td>
<td><p>2
0
7
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
5
5
9
5</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>ERCC excision
repair 4,
endonuclease
catalytic
subunit</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id67"><span class="problematic" id="id68">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Xeroderma
pigmentosum, group F;
Fanconi anemia,
complementation group
Q</p></td>
</tr>
<tr class="row-even"><td><p>1
0
3</p></td>
<td><p>ERCC5</p></td>
<td><p>2
0
7
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
4
8
9
9</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>ERCC excision
repair 5,
endonuclease</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id69"><span class="problematic" id="id70">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Xeroderma
pigmentosum, group G</p></td>
</tr>
<tr class="row-odd"><td><p>1
0
4</p></td>
<td><p>ERCC6</p></td>
<td><p>2
0
7
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
2
5
8
3
0</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>N
A</p></td>
<td><p>ERCC excision
repair 6,
chromatin
remodeling
factor</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
0
5</p></td>
<td><p>ERG</p></td>
<td><p>2
0
7
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
5
7
5
5
4</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>ETS
transcription
factor ERG</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
0
6</p></td>
<td><p>ESR1</p></td>
<td><p>2
0
9
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
9
1
8
3
1</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>estrogen
receptor 1</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
0
7</p></td>
<td><p>ETV6</p></td>
<td><p>2
1
2
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
9
0
8
3</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>ETS variant
transcription
factor 6</p></td>
<td><p>N
CGC,P
<a href="#id71"><span class="problematic" id="id72">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Thrombocytopenia 5</p></td>
</tr>
<tr class="row-odd"><td><p>1
0
8</p></td>
<td><p>EXO1</p></td>
<td><p>9
1
5
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
4
3
7
1</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>exonuclease 1</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
0
9</p></td>
<td><p>EXT1</p></td>
<td><p>2
1
3
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
2
1
9
7</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>exostosin
glycos
yltransferase
1</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id73"><span class="problematic" id="id74">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Chondrosarcoma</p></td>
</tr>
<tr class="row-odd"><td><p>1
1
0</p></td>
<td><p>EXT2</p></td>
<td><p>2
1
3
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
5
1
3
4
8</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>exostosin
glycos
yltransferase
2</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id75"><span class="problematic" id="id76">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Multiple exostoses
type 2</p></td>
</tr>
<tr class="row-even"><td><p>1
1
1</p></td>
<td><p>EZH2</p></td>
<td><p>2
1
4
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
6
4
6
2</p></td>
<td><p>A
D</p></td>
<td><p>L
o
F</p></td>
<td><p>enhancer of
zeste 2
polycomb
repressive
complex 2
subunit</p></td>
<td><p>NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
1
2</p></td>
<td><p>FAH</p></td>
<td><p>2
1
8
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
3
8
7
6</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>fumary
lacetoacetate
hydrolase</p></td>
<td><p>T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
1
3</p></td>
<td><p>FAN1</p></td>
<td><p>2
2
9
0
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
9
8
6
9
0</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>FANCD2 and
FANCI
associated
nuclease 1</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
1
4</p></td>
<td><p>FANCA</p></td>
<td><p>2
1
7
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
7
7
4
1</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>FA
co
mplementation
group A</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id77"><span class="problematic" id="id78">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Fanconi anemia,
complementation group
A</p></td>
</tr>
<tr class="row-even"><td><p>1
1
5</p></td>
<td><p>FANCB</p></td>
<td><p>2
1
8
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
1
5
4
4</p></td>
<td><p>N
A</p></td>
<td><p>L
o
F</p></td>
<td><p>FA
co
mplementation
group B</p></td>
<td><p>NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
1
6</p></td>
<td><p>FANCC</p></td>
<td><p>2
1
7
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
5
8
1
6
9</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>FA
co
mplementation
group C</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id79"><span class="problematic" id="id80">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Fanconi anemia,
complementation group
C</p></td>
</tr>
<tr class="row-even"><td><p>1
1
7</p></td>
<td><p>FANCD2</p></td>
<td><p>2
1
7
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
4
5
5
4</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>FA
co
mplementation
group D2</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id81"><span class="problematic" id="id82">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Fanconi anemia,
complementation group
D2</p></td>
</tr>
<tr class="row-odd"><td><p>1
1
8</p></td>
<td><p>FANCE</p></td>
<td><p>2
1
7
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
2
0
3
9</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>FA
co
mplementation
group E</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id83"><span class="problematic" id="id84">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Fanconi anemia,
complementation group
E</p></td>
</tr>
<tr class="row-even"><td><p>1
1
9</p></td>
<td><p>FANCF</p></td>
<td><p>2
1
8
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
3
1
6
1</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>FA
co
mplementation
group F</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id85"><span class="problematic" id="id86">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Fanconi anemia,
complementation group
F</p></td>
</tr>
<tr class="row-odd"><td><p>1
2
0</p></td>
<td><p>FANCG</p></td>
<td><p>2
1
8
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
2
1
8
2
9</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>FA
co
mplementation
group G</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id87"><span class="problematic" id="id88">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Fanconi anemia,
complementation group
G</p></td>
</tr>
<tr class="row-even"><td><p>1
2
1</p></td>
<td><p>FANCI</p></td>
<td><p>5
5
2
1
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
0
5
2
5</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>FA
co
mplementation
group I</p></td>
<td><p>N
CGC,P
<a href="#id89"><span class="problematic" id="id90">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Fanconi anemia,
complementation group
I</p></td>
</tr>
<tr class="row-odd"><td><p>1
2
2</p></td>
<td><p>FANCL</p></td>
<td><p>5
5
1
2
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
5
3
9
2</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>FA
co
mplementation
group L</p></td>
<td><p>N
CGC,P
<a href="#id91"><span class="problematic" id="id92">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Fanconi anemia,
complementation group
L</p></td>
</tr>
<tr class="row-even"><td><p>1
2
3</p></td>
<td><p>FANCM</p></td>
<td><p>5
7
6
9
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
7
7
9
0</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>FA
co
mplementation
group M</p></td>
<td><p>N
CGC,P
<a href="#id93"><span class="problematic" id="id94">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
2
4</p></td>
<td><p>FAS</p></td>
<td><p>3
5
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
2
6
1
0
3</p></td>
<td><p>A
D</p></td>
<td><p>L
o
F</p></td>
<td><p>Fas cell
surface death
receptor</p></td>
<td><p>P
<a href="#id95"><span class="problematic" id="id96">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Autoimmune
lymphoproliferative
syndrome</p></td>
</tr>
<tr class="row-even"><td><p>1
2
5</p></td>
<td><p>FAT1</p></td>
<td><p>2
1
9
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
8
3
8
5
7</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>FAT atypical
cadherin 1</p></td>
<td><p>C
GC_94</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
2
6</p></td>
<td><p>FBXW7</p></td>
<td><p>5
5
2
9
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
9
6
7
0</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>F-box and WD
repeat domain
containing 7</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
2
7</p></td>
<td><p>FEN1</p></td>
<td><p>2
2
3
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
8
4
9
6</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>flap
struc
ture-specific
endonuclease
1</p></td>
<td><p>C
GC_94</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
2
8</p></td>
<td><p>FGF23</p></td>
<td><p>8
0
7
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
8
9
7
2</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>N
A</p></td>
<td><p>fibroblast
growth factor
23</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
2
9</p></td>
<td><p>FGFR1</p></td>
<td><p>2
2
6
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
7
7
7
8
2</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>fibroblast
growth factor
receptor 1</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
3
0</p></td>
<td><p>FGFR2</p></td>
<td><p>2
2
6
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
6
6
4
6
8</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>fibroblast
growth factor
receptor 2</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
3
1</p></td>
<td><p>FGFR3</p></td>
<td><p>2
2
6
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
6
8
0
7
8</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>fibroblast
growth factor
receptor 3</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
3
2</p></td>
<td><p>FH</p></td>
<td><p>2
2
7
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
9
1
4
8
3</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>fumarate
hydratase</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id97"><span class="problematic" id="id98">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hereditary
leiomyomatosis and
renal cell cancer</p></td>
</tr>
<tr class="row-even"><td><p>1
3
3</p></td>
<td><p>FHIT</p></td>
<td><p>2
2
7
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
9
2
8
3</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>fragile
histidine
triad
diadenosine
t
riphosphatase</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
3
4</p></td>
<td><p>FLCN</p></td>
<td><p>2
0
1
1
6
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
5
4
8
0
3</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>folliculin</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id99"><span class="problematic" id="id100">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
3
5</p></td>
<td><p>FLT3</p></td>
<td><p>2
3
2
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
2
0
2
5</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>fms related
receptor
tyrosine
kinase 3</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
3
6</p></td>
<td><p>FMR1</p></td>
<td><p>2
3
3
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
2
0
8
1</p></td>
<td><p>X
D</p></td>
<td><p>N
A</p></td>
<td><p>FMRP
translational
regulator 1</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
3
7</p></td>
<td><p>FOXE1</p></td>
<td><p>2
3
0
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
8
9
1
9</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>forkhead box
E1</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
3
8</p></td>
<td><p>FOXO1</p></td>
<td><p>2
3
0
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
5
0
9
0
7</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>forkhead box
O1</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
3
9</p></td>
<td><p>FOXO3</p></td>
<td><p>2
3
0
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
8
6
8
9</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>forkhead box
O3</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
4
0</p></td>
<td><p>FOXO4</p></td>
<td><p>4
3
0
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
4
4
8
1</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>forkhead box
O4</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
4
1</p></td>
<td><p>FOXP1</p></td>
<td><p>2
7
0
8
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
4
8
6
1</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>forkhead box
P1</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
4
2</p></td>
<td><p>G6PC1</p></td>
<td><p>2
5
3
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
1
4
8
2</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>glucose-
6-phosphatase
catalytic
subunit 1</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
4
3</p></td>
<td><p>GALNT12</p></td>
<td><p>7
9
6
9
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
9
5
1
4</p></td>
<td><p>A
D</p></td>
<td><p>L
o
F</p></td>
<td><p>polypeptide
N-acety
lgalactosamin
yltransferase
12</p></td>
<td><p>NCGC</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
4
4</p></td>
<td><p>GALNT3</p></td>
<td><p>2
5
9
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
5
3
3
9</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>polypeptide
N-acety
lgalactosamin
yltransferase
3</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
4
5</p></td>
<td><p>GATA1</p></td>
<td><p>2
6
2
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
2
1
4
5</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>GATA binding
protein 1</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
4
6</p></td>
<td><p>GATA2</p></td>
<td><p>2
6
2
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
9
3
4
8</p></td>
<td><p>A
D</p></td>
<td><p>L
o
F</p></td>
<td><p>GATA binding
protein 2</p></td>
<td><p>N
CGC,P
<a href="#id101"><span class="problematic" id="id102">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Dendritic cell,
monocyte, B
lymphocyte, and
natural killer
lymphocyte deficiency</p></td>
</tr>
<tr class="row-even"><td><p>1
4
7</p></td>
<td><p>GATA3</p></td>
<td><p>2
6
2
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
7
4
8
5</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>GATA binding
protein 3</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
4
8</p></td>
<td><p>GBA</p></td>
<td><p>2
6
2
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
7
6
2
8</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>gluco
sylceramidase
beta</p></td>
<td><p>P
<a href="#id103"><span class="problematic" id="id104">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
4
9</p></td>
<td><p>GDNF</p></td>
<td><p>2
6
6
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
8
6
2
1</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>glial cell
derived
neurotrophic
factor</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
5
0</p></td>
<td><p>GJB2</p></td>
<td><p>2
7
0
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
5
4
7
4</p></td>
<td><p>A
D</p></td>
<td><p>L
o
F</p></td>
<td><p>gap junction
protein beta
2</p></td>
<td><p>T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
5
1</p></td>
<td><p>GLA</p></td>
<td><p>2
7
1
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
2
3
9
3</p></td>
<td><p>N
A</p></td>
<td><p>L
o
F</p></td>
<td><p>galactosidase
alpha</p></td>
<td><p>ACMG
_SF30
,PANE
L_APP</p></td>
<td><p>Fabry disease</p></td>
</tr>
<tr class="row-odd"><td><p>1
5
2</p></td>
<td><p>GLI3</p></td>
<td><p>2
7
3
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
6
5
7
1</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>GLI family
zinc finger 3</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
5
3</p></td>
<td><p>GNAS</p></td>
<td><p>2
7
7
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
8
7
4
6
0</p></td>
<td><p>A
D
&amp;
m
o
s
a
i
c</p></td>
<td><p>N
A</p></td>
<td><p>GNAS complex
locus</p></td>
<td><p>OTHER
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
5
4</p></td>
<td><p>GPC3</p></td>
<td><p>2
7
1
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
7
2
5
7</p></td>
<td><p>N
A</p></td>
<td><p>L
o
F</p></td>
<td><p>glypican 3</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id105"><span class="problematic" id="id106">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Simpson-Golabi-Behmel
syndrome type 1</p></td>
</tr>
<tr class="row-even"><td><p>1
5
5</p></td>
<td><p>GPC4</p></td>
<td><p>2
2
3
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
7
6
7
1
6</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>glypican 4</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
5
6</p></td>
<td><p>GPR161</p></td>
<td><p>2
3
4
3
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
3
1
4
7</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>G
pr
otein-coupled
receptor 161</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
5
7</p></td>
<td><p>GREM1</p></td>
<td><p>2
6
5
8
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
6
9
2
3</p></td>
<td><p>A
D</p></td>
<td><p>G
o
F</p></td>
<td><p>gremlin 1,
DAN family
BMP
antagonist</p></td>
<td><p>NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
5
8</p></td>
<td><p>H19</p></td>
<td><p>2
8
3
1
2
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
0
6
0
0</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>H19 imprinted
maternally
expressed
transcript</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
5
9</p></td>
<td><p>HABP2</p></td>
<td><p>3
0
2
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
8
7
0
2</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>hyaluronan
binding
protein 2</p></td>
<td><p>NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
6
0</p></td>
<td><p>HAX1</p></td>
<td><p>1
0
4
5
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
3
5
7
5</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>HCLS1
associated
protein X-1</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
6
1</p></td>
<td><p>HFE</p></td>
<td><p>3
0
7
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
1
0
7
0
4</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>homeostatic
iron
regulator</p></td>
<td><p>A
CMG_S
F30,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hereditary
hemochromatosis</p></td>
</tr>
<tr class="row-odd"><td><p>1
6
2</p></td>
<td><p>HMBS</p></td>
<td><p>3
1
4
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
5
6
2
6
9</p></td>
<td><p>A
D</p></td>
<td><p>L
o
F</p></td>
<td><p>hydrox
ymethylbilane
synthase</p></td>
<td><p>T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
6
3</p></td>
<td><p>HNF1A</p></td>
<td><p>6
9
2
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
5
1
0
0</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>HNF1 homeobox
A</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hepatic adenomas,
familial; NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
6
4</p></td>
<td><p>HNF1B</p></td>
<td><p>6
9
2
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
7
5
4
1
0</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>HNF1 homeobox
B</p></td>
<td><p>NCGC</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
6
5</p></td>
<td><p>HOXB13</p></td>
<td><p>1
0
4
8
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
5
9
1
8
4</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>homeobox B13</p></td>
<td><p>NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
6
6</p></td>
<td><p>HRAS</p></td>
<td><p>3
2
6
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
4
7
7
5</p></td>
<td><p>A
D</p></td>
<td><p>G
o
F</p></td>
<td><p>HRas
pr
oto-oncogene,
GTPase</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id107"><span class="problematic" id="id108">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Costello syndrome</p></td>
</tr>
<tr class="row-even"><td><p>1
6
7</p></td>
<td><p>IDH1</p></td>
<td><p>3
4
1
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
8
4
1
3</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>isocitrate
dehydrogenase
(NADP(+)) 1</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
6
8</p></td>
<td><p>IGF2</p></td>
<td><p>3
4
8
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
7
2
4
4</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>insulin like
growth factor
2</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
6
9</p></td>
<td><p>IGF2R</p></td>
<td><p>3
4
8
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
9
7
0
8
1</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>insulin like
growth factor
2 receptor</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
7
0</p></td>
<td><p>IKZF1</p></td>
<td><p>1
0
3
2
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
5
8
1
1</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>IKAROS family
zinc finger 1</p></td>
<td><p>OTHER
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
7
1</p></td>
<td><p>IKZF3</p></td>
<td><p>2
2
8
0
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
1
4
0
5</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>IKAROS family
zinc finger 3</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
7
2</p></td>
<td><p>IRF4</p></td>
<td><p>3
6
6
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
7
2
6
5</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>interferon
regulatory
factor 4</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
7
3</p></td>
<td><p>ITK</p></td>
<td><p>3
7
0
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
3
2
6
3</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>IL2 inducible
T cell kinase</p></td>
<td><p>P
<a href="#id109"><span class="problematic" id="id110">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Lymphoproliferative
syndrome 1</p></td>
</tr>
<tr class="row-odd"><td><p>1
7
4</p></td>
<td><p>JAK1</p></td>
<td><p>3
7
1
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
2
4
3
4</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>Janus kinase
1</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
7
5</p></td>
<td><p>JAK2</p></td>
<td><p>3
7
1
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
9
6
9
6
8</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>N
A</p></td>
<td><p>Janus kinase
2</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
7
6</p></td>
<td><p>JAK3</p></td>
<td><p>3
7
1
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
5
6
3
9</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>Janus kinase
3</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
7
7</p></td>
<td><p>JMJD1C</p></td>
<td><p>2
2
1
0
3
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
1
9
8
8</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>jumonji
domain
containing 1C</p></td>
<td><p>T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
7
8</p></td>
<td><p>KCNQ1</p></td>
<td><p>3
7
8
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
5
3
9
1
8</p></td>
<td><p>A
D</p></td>
<td><p>L
o
F</p></td>
<td><p>potassium
voltage-gated
channel
subfamily Q
member 1</p></td>
<td><p><a href="#id111"><span class="problematic" id="id112">ACMG_</span></a>
SF30,
OTHER</p></td>
<td><p>Long QT syndrome 1</p></td>
</tr>
<tr class="row-even"><td><p>1
7
9</p></td>
<td><p>KCNQ1OT1</p></td>
<td><p>1
0
9
8
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
6
9
8
2
1</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>KCNQ1
opposite
str
and/antisense
transcript 1</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
8
0</p></td>
<td><p>KDM3B</p></td>
<td><p>5
1
7
8
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
0
7
3
3</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>lysine
demethylase
3B</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
8
1</p></td>
<td><p>KDR</p></td>
<td><p>3
7
9
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
8
0
5
2</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>kinase insert
domain
receptor</p></td>
<td><p>C
GC_94</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
8
2</p></td>
<td><p>KIF1B</p></td>
<td><p>2
3
0
9
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
5
4
5
2
3</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>kinesin
family member
1B</p></td>
<td><p>NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
8
3</p></td>
<td><p>KISS1R</p></td>
<td><p>8
4
6
3
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
6
0
1
4</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>KISS1
receptor</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
8
4</p></td>
<td><p>KIT</p></td>
<td><p>3
8
1
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
5
7
4
0
4</p></td>
<td><p>A
D</p></td>
<td><p>G
o
F</p></td>
<td><p>KIT
pr
oto-oncogene,
receptor
tyrosine
kinase</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id113"><span class="problematic" id="id114">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Gastrointestinal
stromal tumor</p></td>
</tr>
<tr class="row-even"><td><p>1
8
5</p></td>
<td><p>KITLG</p></td>
<td><p>4
2
5
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
4
9
1
3
0</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>KIT ligand</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
8
6</p></td>
<td><p>KLF6</p></td>
<td><p>1
3
1
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
6
7
0
8
2</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>Kruppel like
factor 6</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
8
7</p></td>
<td><p>KLLN</p></td>
<td><p>1
0
0
1
4
4
7
4
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
2
7
2
6
8</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>killin, p53
regulated DNA
replication
inhibitor</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
8
8</p></td>
<td><p>KMT2D</p></td>
<td><p>8
0
8
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
7
5
4
8</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>lysine
meth
yltransferase
2D</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
8
9</p></td>
<td><p>KRAS</p></td>
<td><p>3
8
4
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
3
7
0
3</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>N
A</p></td>
<td><p>KRAS
pr
oto-oncogene,
GTPase</p></td>
<td><p>P
<a href="#id115"><span class="problematic" id="id116">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Noonan syndrome 3;
RAS-associated
autoimmune
leukoproliferative
disorder</p></td>
</tr>
<tr class="row-odd"><td><p>1
9
0</p></td>
<td><p>KRT17</p></td>
<td><p>3
8
7
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
8
4
2
2</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>keratin 17</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
9
1</p></td>
<td><p>L2HGDH</p></td>
<td><p>7
9
9
4
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
8
7
2
9
9</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>L-2-hyd
roxyglutarate
dehydrogenase</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
9
2</p></td>
<td><p>LCK</p></td>
<td><p>3
9
3
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
2
8
6
6</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>LCK
pr
oto-oncogene,
Src family
tyrosine
kinase</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
9
3</p></td>
<td><p>LEF1</p></td>
<td><p>5
1
1
7
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
8
7
9
5</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>lymphoid
enhancer
binding
factor 1</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
9
4</p></td>
<td><p>LEMD3</p></td>
<td><p>2
3
5
9
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
4
1
0
6</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>LEM domain
containing 3</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
9
5</p></td>
<td><p>LIG4</p></td>
<td><p>3
9
8
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
4
4
0
5</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>DNA ligase 4</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
9
6</p></td>
<td><p>LMO1</p></td>
<td><p>4
0
0
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
6
4
0
7</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>LIM domain
only 1</p></td>
<td><p>CGC
_94,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Neuroblastoma,
susceptibility to, 7</p></td>
</tr>
<tr class="row-even"><td><p>1
9
7</p></td>
<td><p>LRIG3</p></td>
<td><p>1
2
1
2
2
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
9
2
6
3</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>leucine rich
repeats and
i
mmunoglobulin
like domains
3</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>1
9
8</p></td>
<td><p>LZTR1</p></td>
<td><p>8
2
1
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
9
9
9
4
9</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>N
A</p></td>
<td><p>leucine
zipper like
transcription
regulator 1</p></td>
<td><p>C
GC_94
,NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>1
9
9</p></td>
<td><p>MAD2L2</p></td>
<td><p>1
0
4
5
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
6
6
7
0</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>mitotic
arrest
deficient 2
like 2</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
0
0</p></td>
<td><p>MAF</p></td>
<td><p>4
0
9
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
8
5
7
3</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>MAF bZIP
transcription
factor</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
0
1</p></td>
<td><p>MAFB</p></td>
<td><p>9
9
3
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
0
4
1
0
3</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>MAF bZIP
transcription
factor B</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
0
2</p></td>
<td><p>MAP2K1</p></td>
<td><p>5
6
0
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
9
0
3
2</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>mito
gen-activated
protein
kinase kinase
1</p></td>
<td><p>P
<a href="#id117"><span class="problematic" id="id118">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
0
3</p></td>
<td><p>MAP2K2</p></td>
<td><p>5
6
0
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
6
9
3
4</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>mito
gen-activated
protein
kinase kinase
2</p></td>
<td><p>P
<a href="#id119"><span class="problematic" id="id120">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
0
4</p></td>
<td><p>MAP2K4</p></td>
<td><p>6
4
1
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
6
5
5
5
9</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>mito
gen-activated
protein
kinase kinase
4</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
0
5</p></td>
<td><p>MAP3K1</p></td>
<td><p>4
2
1
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
9
5
0
1
5</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>mito
gen-activated
protein
kinase kinase
kinase 1</p></td>
<td><p>NCGC</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
0
6</p></td>
<td><p>MAX</p></td>
<td><p>4
1
4
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
5
9
5
2</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>MYC
associated
factor X</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id121"><span class="problematic" id="id122">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hereditary
Paragangl
ioma-Pheochromocytoma
Syndromes</p></td>
</tr>
<tr class="row-even"><td><p>2
0
7</p></td>
<td><p>MBD4</p></td>
<td><p>8
9
3
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
9
0
7
1</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>methyl-CpG
binding
domain 4, DNA
glycosylase</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
0
8</p></td>
<td><p>MC1R</p></td>
<td><p>4
1
5
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
5
8
8
3
9</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>melanocortin
1 receptor</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
0
9</p></td>
<td><p>MDH2</p></td>
<td><p>4
1
9
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
6
7
0
1</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>malate
dehydrogenase
2</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
1
0</p></td>
<td><p>MEN1</p></td>
<td><p>4
2
2
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
3
8
9
5</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>menin 1</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id123"><span class="problematic" id="id124">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Multiple endocrine
neoplasia, type 1</p></td>
</tr>
<tr class="row-even"><td><p>2
1
1</p></td>
<td><p>MET</p></td>
<td><p>4
2
3
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
5
9
7
6</p></td>
<td><p>A
D</p></td>
<td><p>G
o
F</p></td>
<td><p>MET
pr
oto-oncogene,
receptor
tyrosine
kinase</p></td>
<td><p>N
CGC,P
<a href="#id125"><span class="problematic" id="id126">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Renal cell carcinoma</p></td>
</tr>
<tr class="row-odd"><td><p>2
1
2</p></td>
<td><p>MINPP1</p></td>
<td><p>9
5
6
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
7
7
8
9</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>multiple
inositol-
polyphosphate
phosphatase 1</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
1
3</p></td>
<td><p>MITF</p></td>
<td><p>4
2
8
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
7
0
9
8</p></td>
<td><p>A
D</p></td>
<td><p>G
o
F</p></td>
<td><p>melanocyte
inducing
transcription
factor</p></td>
<td><p>N
CGC,P
<a href="#id127"><span class="problematic" id="id128">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hereditary melanoma</p></td>
</tr>
<tr class="row-odd"><td><p>2
1
4</p></td>
<td><p>MLH1</p></td>
<td><p>4
2
9
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
7
6
2
4
2</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>mutL homolog
1</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id129"><span class="problematic" id="id130">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hereditary
nonpolyposis
colorectal neoplasms;
Turcot syndrome;
Hereditary
nonpolyposis colon
cancer; Lynch
syndrome</p></td>
</tr>
<tr class="row-even"><td><p>2
1
5</p></td>
<td><p>MLH3</p></td>
<td><p>2
7
0
3
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
9
6
8
4</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>mutL homolog
3</p></td>
<td><p>NCGC</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
1
6</p></td>
<td><p>MN1</p></td>
<td><p>4
3
3
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
9
1
8
4</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>MN1
pr
oto-oncogene,
tr
anscriptional
regulator</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
1
7</p></td>
<td><p>MPL</p></td>
<td><p>4
3
5
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
7
4
0
0</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>MPL
pr
oto-oncogene,
t
hrombopoietin
receptor</p></td>
<td><p>CGC
_94,T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
1
8</p></td>
<td><p>MRE11</p></td>
<td><p>4
3
6
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
2
0
9
2
2</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>MRE11
homolog,
double strand
break repair
nuclease</p></td>
<td><p>NCGC</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
1
9</p></td>
<td><p>MSH2</p></td>
<td><p>4
4
3
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
9
5
0
0
2</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>mutS homolog
2</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id131"><span class="problematic" id="id132">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hereditary
nonpolyposis
colorectal neoplasms;
Turcot syndrome;
Hereditary
nonpolyposis colon
cancer; Lynch
syndrome</p></td>
</tr>
<tr class="row-odd"><td><p>2
2
0</p></td>
<td><p>MSH3</p></td>
<td><p>4
4
3
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
3
3
1
8</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>mutS homolog
3</p></td>
<td><p>NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
2
1</p></td>
<td><p>MSH5</p></td>
<td><p>4
4
3
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
0
4
4
1
0</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>mutS homolog
5</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
2
2</p></td>
<td><p>MSH6</p></td>
<td><p>2
9
5
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
6
0
6
2</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>mutS homolog
6</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id133"><span class="problematic" id="id134">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hereditary
nonpolyposis
colorectal neoplasms;
Turcot syndrome;
Hereditary
nonpolyposis colon
cancer; Lynch
syndrome</p></td>
</tr>
<tr class="row-even"><td><p>2
2
3</p></td>
<td><p>MSR1</p></td>
<td><p>4
4
8
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
3
8
9
4
5</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>macrophage
scavenger
receptor 1</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
2
4</p></td>
<td><p>MTAP</p></td>
<td><p>4
5
0
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
9
9
8
1
0</p></td>
<td><p>A
D</p></td>
<td><p>L
o
F</p></td>
<td><p>methyl
thioadenosine
phosphorylase</p></td>
<td><p>P
<a href="#id135"><span class="problematic" id="id136">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Diaphyseal medullary
stenosis-bone
malignancy syndrome</p></td>
</tr>
<tr class="row-even"><td><p>2
2
5</p></td>
<td><p>MUC1</p></td>
<td><p>4
5
8
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
5
4
9
9</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>mucin 1, cell
surface
associated</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
2
6</p></td>
<td><p>MUC5B</p></td>
<td><p>7
2
7
8
9
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
7
9
8
3</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>mucin 5B,
oligomeric
mucu
s/gel-forming</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
2
7</p></td>
<td><p>MUTYH</p></td>
<td><p>4
5
9
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
2
7
8
1</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>mutY DNA
glycosylase</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id137"><span class="problematic" id="id138">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>MYH-associated
polyposis</p></td>
</tr>
<tr class="row-odd"><td><p>2
2
8</p></td>
<td><p>MYCN</p></td>
<td><p>4
6
1
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
4
3
2
3</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>MYCN
pr
oto-oncogene,
bHLH
transcription
factor</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
2
9</p></td>
<td><p>NAF1</p></td>
<td><p>9
2
3
4
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
5
4
1
4</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>nuclear
assembly
factor 1
ribo
nucleoprotein</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
3
0</p></td>
<td><p>NBN</p></td>
<td><p>4
6
8
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
4
3
2
0</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>nibrin</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id139"><span class="problematic" id="id140">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Microcephaly, normal
intelligence and
immunodeficiency</p></td>
</tr>
<tr class="row-even"><td><p>2
3
1</p></td>
<td><p>NCOA4</p></td>
<td><p>8
0
3
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
6
6
4
1
2</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>nuclear
receptor
coactivator 4</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
3
2</p></td>
<td><p>NDRG1</p></td>
<td><p>1
0
3
9
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
4
4
1
9</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>N-myc
downstream
regulated 1</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
3
3</p></td>
<td><p>NDUFA13</p></td>
<td><p>5
1
0
7
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
6
0
1
0</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>NA
DH:ubiquinone
o
xidoreductase
subunit A13</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
3
4</p></td>
<td><p>NF1</p></td>
<td><p>4
7
6
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
9
6
7
1
2</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>neurofibromin
1</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id141"><span class="problematic" id="id142">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Neurofibromatosis,
type 1</p></td>
</tr>
<tr class="row-even"><td><p>2
3
5</p></td>
<td><p>NF2</p></td>
<td><p>4
7
7
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
6
5
7
5</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>neurofibromin
2</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id143"><span class="problematic" id="id144">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Neurofibromatosis,
type 2</p></td>
</tr>
<tr class="row-odd"><td><p>2
3
6</p></td>
<td><p>NFIX</p></td>
<td><p>4
7
8
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
0
8
4
4
1</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>nuclear
factor I X</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
3
7</p></td>
<td><p>NHP2</p></td>
<td><p>5
5
6
5
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
5
9
1
2</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>NHP2
ribo
nucleoprotein</p></td>
<td><p>P
<a href="#id145"><span class="problematic" id="id146">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Dyskeratosis
congenita, autosomal
recessive 2</p></td>
</tr>
<tr class="row-odd"><td><p>2
3
8</p></td>
<td><p>NKX2-1</p></td>
<td><p>7
0
8
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
6
3
5
2</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>NK2 homeobox
1</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
3
9</p></td>
<td><p>NOP10</p></td>
<td><p>5
5
5
0
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
2
1
1
7</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>NOP10
ribo
nucleoprotein</p></td>
<td><p>P
<a href="#id147"><span class="problematic" id="id148">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Dyskeratosis
congenita autosomal
recessive 1</p></td>
</tr>
<tr class="row-odd"><td><p>2
4
0</p></td>
<td><p>NOTCH1</p></td>
<td><p>4
8
5
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
8
4
0
0</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>notch
receptor 1</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
4
1</p></td>
<td><p>NOTCH3</p></td>
<td><p>4
8
5
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
7
4
1
8
1</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>notch
receptor 3</p></td>
<td><p>NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
4
2</p></td>
<td><p>NR4A3</p></td>
<td><p>8
0
1
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
9
5
0
8</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>nuclear
receptor
subfamily 4
group A
member 3</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
4
3</p></td>
<td><p>NRAS</p></td>
<td><p>4
8
9
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
1
3
2
8
1</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>NRAS
pr
oto-oncogene,
GTPase</p></td>
<td><p>P
<a href="#id149"><span class="problematic" id="id150">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA; Epidermal nevus;
Large congenital
melanocytic nevus;
RAS-associated
autoimmune
leukoproliferative
disorder; Noonan
syndrome 6; Rasopathy</p></td>
</tr>
<tr class="row-odd"><td><p>2
4
4</p></td>
<td><p>NSD1</p></td>
<td><p>6
4
3
2
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
5
6
7
1</p></td>
<td><p>A
D</p></td>
<td><p>L
o
F</p></td>
<td><p>nuclear
receptor
binding SET
domain
protein 1</p></td>
<td><p>NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
4
5</p></td>
<td><p>NTHL1</p></td>
<td><p>4
9
1
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
6
5
0
5
7</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>nth like DNA
glycosylase 1</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id151"><span class="problematic" id="id152">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Familial adenomatous
polyposis 3</p></td>
</tr>
<tr class="row-odd"><td><p>2
4
6</p></td>
<td><p>NTRK1</p></td>
<td><p>4
9
1
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
9
8
4
0
0</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>neurotrophic
receptor
tyrosine
kinase 1</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
4
7</p></td>
<td><p>NTRK3</p></td>
<td><p>4
9
1
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
0
5
3
8</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>neurotrophic
receptor
tyrosine
kinase 3</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
4
8</p></td>
<td><p>NYNRIN</p></td>
<td><p>5
7
5
2
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
0
5
9
7
8</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>NYN domain
and
retroviral
integrase
containing</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
4
9</p></td>
<td><p>OGG1</p></td>
<td><p>4
9
6
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
4
0
2
6</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>8-oxoguanine
DNA
glycosylase</p></td>
<td><p>NCGC</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
5
0</p></td>
<td><p>PALB2</p></td>
<td><p>7
9
7
2
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
8
3
0
9
3</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>partner and
localizer of
BRCA2</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id153"><span class="problematic" id="id154">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Familial cancer of
breast; Fanconi
anemia,
complementation group
N</p></td>
</tr>
<tr class="row-even"><td><p>2
5
1</p></td>
<td><p>PARN</p></td>
<td><p>5
0
7
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
0
6
9
4</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>N
A</p></td>
<td><p>pol
y(A)-specific
ribonuclease</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
5
2</p></td>
<td><p>PAX3</p></td>
<td><p>5
0
7
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
5
9
0
3</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>paired box 3</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
5
3</p></td>
<td><p>PAX5</p></td>
<td><p>5
0
7
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
9
6
0
9
2</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>paired box 5</p></td>
<td><p>N
CGC,P
<a href="#id155"><span class="problematic" id="id156">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Leukemia, acute
lymphoblastic,
susceptibility to, 3</p></td>
</tr>
<tr class="row-odd"><td><p>2
5
4</p></td>
<td><p>PAX6</p></td>
<td><p>5
0
8
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
0
7
3
7
2</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>paired box 6</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
5
5</p></td>
<td><p>PAX7</p></td>
<td><p>5
0
8
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
0
9
7
0
9</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>paired box 7</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
5
6</p></td>
<td><p>PBRM1</p></td>
<td><p>5
5
1
9
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
3
9
3
9</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>polybromo 1</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
5
7</p></td>
<td><p>PDGFRA</p></td>
<td><p>5
1
5
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
4
8
5
3</p></td>
<td><p>A
D</p></td>
<td><p>G
o
F</p></td>
<td><p>platelet
derived
growth factor
receptor
alpha</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id157"><span class="problematic" id="id158">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Gastrointestinal
stromal tumor</p></td>
</tr>
<tr class="row-odd"><td><p>2
5
8</p></td>
<td><p>PDGFRB</p></td>
<td><p>5
1
5
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
3
7
2
1</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>platelet
derived
growth factor
receptor beta</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
5
9</p></td>
<td><p>PHF6</p></td>
<td><p>8
4
2
9
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
5
6
5
3
1</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>PHD finger
protein 6</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
6
0</p></td>
<td><p>PHOX2B</p></td>
<td><p>8
9
2
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
9
1
3
2</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>paired like
homeobox 2B</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id159"><span class="problematic" id="id160">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Neuroblastoma 2</p></td>
</tr>
<tr class="row-even"><td><p>2
6
1</p></td>
<td><p>PIK3CA</p></td>
<td><p>5
2
9
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
1
8
7
9</p></td>
<td><p>A
D</p></td>
<td><p>G
o
F</p></td>
<td><p>phosphatidy
linositol-4,5
-bisphosphate
3-kinase
catalytic
subunit alpha</p></td>
<td><p>NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
6
2</p></td>
<td><p>PINK1</p></td>
<td><p>6
5
0
1
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
5
8
8
2
8</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>PTEN induced
kinase 1</p></td>
<td><p>NCGC</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
6
3</p></td>
<td><p>PML</p></td>
<td><p>5
3
7
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
0
4
6
4</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>PML nuclear
body scaffold</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
6
4</p></td>
<td><p>PMS1</p></td>
<td><p>5
3
7
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
6
4
9
3
3</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>PMS1 homolog
1, mismatch
repair system
component</p></td>
<td><p>CGC
_94,N
CGC,T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
6
5</p></td>
<td><p>PMS2</p></td>
<td><p>5
3
9
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
2
5
1
2</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>PMS1 homolog
2, mismatch
repair system
component</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id161"><span class="problematic" id="id162">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hereditary
nonpolyposis
colorectal neoplasms;
Turcot syndrome;
Hereditary
nonpolyposis colon
cancer; Lynch
syndrome</p></td>
</tr>
<tr class="row-odd"><td><p>2
6
6</p></td>
<td><p>POLA1</p></td>
<td><p>5
4
2
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
1
8
6
8</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>DNA
polymerase
alpha 1,
catalytic
subunit</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
6
7</p></td>
<td><p>POLD1</p></td>
<td><p>5
4
2
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
6
2
8
2
2</p></td>
<td><p>A
D</p></td>
<td><p>L
o
F</p></td>
<td><p>DNA
polymerase
delta 1,
catalytic
subunit</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id163"><span class="problematic" id="id164">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
6
8</p></td>
<td><p>POLE</p></td>
<td><p>5
4
2
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
7
0
8
4</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>DNA
polymerase
epsilon,
catalytic
subunit</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id165"><span class="problematic" id="id166">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
6
9</p></td>
<td><p>POLH</p></td>
<td><p>5
4
2
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
0
7
3
4</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>DNA
polymerase
eta</p></td>
<td><p>P
<a href="#id167"><span class="problematic" id="id168">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Xeroderma pigmentosum
variant type</p></td>
</tr>
<tr class="row-odd"><td><p>2
7
0</p></td>
<td><p>POLQ</p></td>
<td><p>1
0
7
2
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
5
1
3
4
1</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>DNA
polymerase
theta</p></td>
<td><p>C
GC_94</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
7
1</p></td>
<td><p>PORCN</p></td>
<td><p>6
4
8
4
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
2
3
1
2</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>porcupine
O-ac
yltransferase</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
7
2</p></td>
<td><p>POT1</p></td>
<td><p>2
5
9
1
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
8
5
1
3</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>protection of
telomeres 1</p></td>
<td><p>N
CGC,P
<a href="#id169"><span class="problematic" id="id170">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Melanoma, cutaneous
malignant,
susceptibility to, 10</p></td>
</tr>
<tr class="row-even"><td><p>2
7
3</p></td>
<td><p>PPM1D</p></td>
<td><p>8
4
9
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
0
8
3
6</p></td>
<td><p>N
A</p></td>
<td><p>L
o
F</p></td>
<td><p>protein
phosphatase,
Mg2+/Mn2+
dependent 1D</p></td>
<td><p>NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
7
4</p></td>
<td><p>PPP1CB</p></td>
<td><p>5
5
0
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
1
3
6
3
9</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>protein
phosphatase 1
catalytic
subunit beta</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
7
5</p></td>
<td><p>PRDM1</p></td>
<td><p>6
3
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
5
7
6
5
7</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>PR/SET domain
1</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
7
6</p></td>
<td><p>PRDM9</p></td>
<td><p>5
6
9
7
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
4
2
5
6</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>PR/SET domain
9</p></td>
<td><p>T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
7
7</p></td>
<td><p>PRF1</p></td>
<td><p>5
5
5
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
0
6
4
4</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>perforin 1</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id171"><span class="problematic" id="id172">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Familial
hemophagocytic
lymphohistiocytosis 2</p></td>
</tr>
<tr class="row-odd"><td><p>2
7
8</p></td>
<td><p>PRKAR1A</p></td>
<td><p>5
5
7
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
8
9
4
6</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>protein
kinase
c
AMP-dependent
type I
regulatory
subunit alpha</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id173"><span class="problematic" id="id174">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Carney complex</p></td>
</tr>
<tr class="row-even"><td><p>2
7
9</p></td>
<td><p>PRKN</p></td>
<td><p>5
0
7
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
5
3
4
5</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>parkin RBR E3
ubiquitin
protein
ligase</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
8
0</p></td>
<td><p>PRSS1</p></td>
<td><p>5
6
4
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
0
4
9
8
3</p></td>
<td><p>A
D</p></td>
<td><p>L
o
F</p></td>
<td><p>serine
protease 1</p></td>
<td><p>N
CGC,P
<a href="#id175"><span class="problematic" id="id176">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hereditary
pancreatitis</p></td>
</tr>
<tr class="row-even"><td><p>2
8
1</p></td>
<td><p>PTCH1</p></td>
<td><p>5
7
2
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
5
9
2
0</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>patched 1</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id177"><span class="problematic" id="id178">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Gorlin syndrome</p></td>
</tr>
<tr class="row-odd"><td><p>2
8
2</p></td>
<td><p>PTCH2</p></td>
<td><p>8
6
4
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
7
4
2
5</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>patched 2</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
8
3</p></td>
<td><p>PTCSC1</p></td>
<td><p>1
0
0
3
0
2
5
2
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
8
7
7
3
6</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>papillary
thyroid
carcinoma
s
usceptibility
candidate 1</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
8
4</p></td>
<td><p>PTCSC3</p></td>
<td><p>1
0
0
8
8
6
9
6
4</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>papillary
thyroid
carcinoma
s
usceptibility
candidate 3</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
8
5</p></td>
<td><p>PTEN</p></td>
<td><p>5
7
2
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
1
8
6
2</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>phosphatase
and tensin
homolog</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id179"><span class="problematic" id="id180">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>PTEN hamartoma tumor
syndrome; Cowden
syndrome 1</p></td>
</tr>
<tr class="row-odd"><td><p>2
8
6</p></td>
<td><p>PTPN11</p></td>
<td><p>5
7
8
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
9
2
9
5</p></td>
<td><p>A
D</p></td>
<td><p>G
o
F</p></td>
<td><p>protein
tyrosine
phosphatase
non-receptor
type 11</p></td>
<td><p>N
CGC,P
<a href="#id181"><span class="problematic" id="id182">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Noonan syndrome</p></td>
</tr>
<tr class="row-even"><td><p>2
8
7</p></td>
<td><p>PTPN12</p></td>
<td><p>5
7
8
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
7
9
4
7</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>protein
tyrosine
phosphatase
non-receptor
type 12</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
8
8</p></td>
<td><p>PTPN13</p></td>
<td><p>5
7
8
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
3
6
2
9</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>protein
tyrosine
phosphatase
non-receptor
type 13</p></td>
<td><p>C
GC_94</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
8
9</p></td>
<td><p>PTPRJ</p></td>
<td><p>5
7
9
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
9
1
7
7</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>protein
tyrosine
phosphatase
receptor type
J</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
9
0</p></td>
<td><p>RABL3</p></td>
<td><p>2
8
5
2
8
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
4
8
4
0</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>RAB, member
of RAS
oncogene
family like 3</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
9
1</p></td>
<td><p>RAD50</p></td>
<td><p>1
0
1
1
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
3
5
2
2</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>RAD50 double
strand break
repair
protein</p></td>
<td><p>NCGC</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
9
2</p></td>
<td><p>RAD51</p></td>
<td><p>5
8
8
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
5
1
1
8
0</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>RAD51
recombinase</p></td>
<td><p>NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
9
3</p></td>
<td><p>RAD51B</p></td>
<td><p>5
8
9
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
2
1
8
5</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>RAD51 paralog
B</p></td>
<td><p>NCGC</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>2
9
4</p></td>
<td><p>RAD51C</p></td>
<td><p>5
8
8
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
8
3
8
4</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>RAD51 paralog
C</p></td>
<td><p>N
CGC,P
<a href="#id183"><span class="problematic" id="id184">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Fanconi anemia,
complementation group
O</p></td>
</tr>
<tr class="row-even"><td><p>2
9
5</p></td>
<td><p>RAD51D</p></td>
<td><p>5
8
9
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
5
3
7
9</p></td>
<td><p>A
D</p></td>
<td><p>L
o
F</p></td>
<td><p>RAD51 paralog
D</p></td>
<td><p>N
CGC,P
<a href="#id185"><span class="problematic" id="id186">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Breast-ovarian
cancer, familial 4</p></td>
</tr>
<tr class="row-odd"><td><p>2
9
6</p></td>
<td><p>RAD54L</p></td>
<td><p>8
4
3
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
8
5
9
9
9</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>RAD54 like</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
9
7</p></td>
<td><p>RAF1</p></td>
<td><p>5
8
9
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
2
1
5
5</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>Raf-1
pr
oto-oncogene,
ser
ine/threonine
kinase</p></td>
<td><p>P
<a href="#id187"><span class="problematic" id="id188">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>LEOPARD syndrome 2;
Noonan syndrome 5</p></td>
</tr>
<tr class="row-odd"><td><p>2
9
8</p></td>
<td><p>RASA1</p></td>
<td><p>5
9
2
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
5
7
1
5</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>RAS p21
protein
activator 1</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>2
9
9</p></td>
<td><p>RB1</p></td>
<td><p>5
9
2
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
9
6
8
7</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>RB
tr
anscriptional
corepressor 1</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id189"><span class="problematic" id="id190">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Osteosarcoma;
Retinoblastoma</p></td>
</tr>
<tr class="row-odd"><td><p>3
0
0</p></td>
<td><p>RCC2</p></td>
<td><p>5
5
9
2
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
9
0
5
1</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>regulator of
chromosome
condensation
2</p></td>
<td><p>NCGC</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
0
1</p></td>
<td><p>RECQL</p></td>
<td><p>5
9
6
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
0
4
7
0
0</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>RecQ like
helicase</p></td>
<td><p>T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
0
2</p></td>
<td><p>RECQL4</p></td>
<td><p>9
4
0
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
0
9
5
7</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>RecQ like
helicase 4</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id191"><span class="problematic" id="id192">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Rothmund-Thomson
syndrome</p></td>
</tr>
<tr class="row-even"><td><p>3
0
3</p></td>
<td><p>REST</p></td>
<td><p>5
9
7
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
8
4
0
9
3</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>RE1 silencing
transcription
factor</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
0
4</p></td>
<td><p>RET</p></td>
<td><p>5
9
7
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
5
7
3
1</p></td>
<td><p>A
D</p></td>
<td><p>G
o
F</p></td>
<td><p>ret
p
roto-oncogene</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id193"><span class="problematic" id="id194">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Multiple endocrine
neoplasia, type 2a;
Multiple endocrine
neoplasia, type 2b;
Familial medullary
thyroid carcinoma</p></td>
</tr>
<tr class="row-even"><td><p>3
0
5</p></td>
<td><p>RFWD3</p></td>
<td><p>5
5
1
5
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
8
4
1
1</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>ring finger
and WD repeat
domain 3</p></td>
<td><p>C
GC_94</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
0
6</p></td>
<td><p>RHBDF2</p></td>
<td><p>7
9
6
5
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
9
6
6
7</p></td>
<td><p>A
D</p></td>
<td><p>G
o
F</p></td>
<td><p>rhomboid 5
homolog 2</p></td>
<td><p>N
CGC,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Palmoplantar
k
eratoderma-esophageal
carcinoma syndrome</p></td>
</tr>
<tr class="row-even"><td><p>3
0
7</p></td>
<td><p>RING1</p></td>
<td><p>6
0
1
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
0
4
2
2
7</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>ring finger
protein 1</p></td>
<td><p>NCGC</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
0
8</p></td>
<td><p>RINT1</p></td>
<td><p>6
0
5
6
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
5
2
4
9</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>RAD50
interactor 1</p></td>
<td><p>NCGC</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
0
9</p></td>
<td><p>RIT1</p></td>
<td><p>6
0
1
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
3
6
2
2</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>Ras like
without CAAX
1</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
1
0</p></td>
<td><p>RMRP</p></td>
<td><p>6
0
2
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
6
9
9
0
0</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>RNA component
of
mitochondrial
RNA
processing
end
oribonuclease</p></td>
<td><p>P
<a href="#id195"><span class="problematic" id="id196">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Metaphyseal
chondrodysplasia,
McKusick type</p></td>
</tr>
<tr class="row-even"><td><p>3
1
1</p></td>
<td><p>RNASEL</p></td>
<td><p>6
0
4
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
5
8
2
8</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>ribonuclease
L</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
1
2</p></td>
<td><p>RNF43</p></td>
<td><p>5
4
8
9
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
8
3
7
5</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>ring finger
protein 43</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
1
3</p></td>
<td><p>ROS1</p></td>
<td><p>6
0
9
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
4
7
9
3
6</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>ROS
p
roto-oncogene
1, receptor
tyrosine
kinase</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
1
4</p></td>
<td><p>RPL11</p></td>
<td><p>6
1
3
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
2
6
7
6</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>ribosomal
protein L11</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
1
5</p></td>
<td><p>RPL15</p></td>
<td><p>6
1
3
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
4
7
4
8</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>ribosomal
protein L15</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
1
6</p></td>
<td><p>RPL23</p></td>
<td><p>9
3
4
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
5
6
9
1</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>ribosomal
protein L23</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
1
7</p></td>
<td><p>RPL26</p></td>
<td><p>6
1
5
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
1
9
7
0</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>ribosomal
protein L26</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
1
8</p></td>
<td><p>RPL27</p></td>
<td><p>6
1
5
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
1
4
6
9</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>ribosomal
protein L27</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
1
9</p></td>
<td><p>RPL31</p></td>
<td><p>6
1
6
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
7
1
0
8
2</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>ribosomal
protein L31</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
2
0</p></td>
<td><p>RPL35A</p></td>
<td><p>6
1
6
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
2
8
9
9</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>ribosomal
protein L35a</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
2
1</p></td>
<td><p>RPL36</p></td>
<td><p>2
5
8
7
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
0
2
5
5</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>ribosomal
protein L36</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
2
2</p></td>
<td><p>RPL5</p></td>
<td><p>6
1
2
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
2
4
0
6</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>ribosomal
protein L5</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
2
3</p></td>
<td><p>RPS10</p></td>
<td><p>6
2
0
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
4
6
1
4</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>ribosomal
protein S10</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
2
4</p></td>
<td><p>RPS15</p></td>
<td><p>6
2
0
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
5
2
6
8</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>ribosomal
protein S15</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
2
5</p></td>
<td><p>RPS17</p></td>
<td><p>6
2
1
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
2
7
7
4</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>ribosomal
protein S17</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
2
6</p></td>
<td><p>RPS19</p></td>
<td><p>6
2
2
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
5
3
7
2</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>ribosomal
protein S19</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
2
7</p></td>
<td><p>RPS24</p></td>
<td><p>6
2
2
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
8
3
2
6</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>ribosomal
protein S24</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
2
8</p></td>
<td><p>RPS26</p></td>
<td><p>6
2
3
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
9
7
7
2
8</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>ribosomal
protein S26</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
2
9</p></td>
<td><p>RPS27</p></td>
<td><p>6
2
3
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
7
9
5
4</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>ribosomal
protein S27</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
3
0</p></td>
<td><p>RPS27A</p></td>
<td><p>6
2
3
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
3
9
4
7</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>ribosomal
protein S27a</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
3
1</p></td>
<td><p>RPS28</p></td>
<td><p>6
2
3
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
3
3
9
2
7</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>ribosomal
protein S28</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
3
2</p></td>
<td><p>RPS29</p></td>
<td><p>6
2
3
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
1
3
7
4
1</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>ribosomal
protein S29</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
3
3</p></td>
<td><p>RPS7</p></td>
<td><p>6
2
0
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
1
8
6
3</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>ribosomal
protein S7</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
3
4</p></td>
<td><p>RRAS2</p></td>
<td><p>2
2
8
0
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
3
8
1
8</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>RAS related 2</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
3
5</p></td>
<td><p>RTEL1</p></td>
<td><p>5
1
7
5
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
5
8
3
6
6</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>N
A</p></td>
<td><p>regulator of
telomere
elongation
helicase 1</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
3
6</p></td>
<td><p>RUNX1</p></td>
<td><p>8
6
1</p></td>
<td><p>N
A</p></td>
<td><p>A
D</p></td>
<td><p>L
o
F</p></td>
<td><p>RUNX family
transcription
factor 1</p></td>
<td><p>N
CGC,P
<a href="#id197"><span class="problematic" id="id198">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Familial platelet
disorder with
associated myeloid
malignancy</p></td>
</tr>
<tr class="row-even"><td><p>3
3
7</p></td>
<td><p>SAMD9</p></td>
<td><p>5
4
8
0
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
0
5
4
1
3</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>N
A</p></td>
<td><p>sterile alpha
motif domain
containing 9</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
3
8</p></td>
<td><p>SAMD9L</p></td>
<td><p>2
1
9
2
8
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
7
4
0
9</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>sterile alpha
motif domain
containing 9
like</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
3
9</p></td>
<td><p>SASH1</p></td>
<td><p>2
3
3
2
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
1
9
6
1</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>N
A</p></td>
<td><p>SAM and SH3
domain
containing 1</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
4
0</p></td>
<td><p>SBDS</p></td>
<td><p>5
1
1
1
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
6
5
2
4</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>SBDS ribosome
maturation
factor</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id199"><span class="problematic" id="id200">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Shwachman syndrome</p></td>
</tr>
<tr class="row-even"><td><p>3
4
1</p></td>
<td><p>SCG5</p></td>
<td><p>6
4
4
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
6
9
2
2</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>secretogranin
V</p></td>
<td><p>NCGC</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
4
2</p></td>
<td><p>SDHA</p></td>
<td><p>6
3
8
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
7
3
5
7
8</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>succinate
dehydrogenase
complex
flavoprotein
subunit A</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id201"><span class="problematic" id="id202">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Paragangliomas 5</p></td>
</tr>
<tr class="row-even"><td><p>3
4
3</p></td>
<td><p>SDHAF2</p></td>
<td><p>5
4
9
4
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
7
9
8
5</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>succinate
dehydrogenase
complex
assembly
factor 2</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id203"><span class="problematic" id="id204">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hereditary
Paragangl
ioma-Pheochromocytoma
Syndromes</p></td>
</tr>
<tr class="row-odd"><td><p>3
4
4</p></td>
<td><p>SDHB</p></td>
<td><p>6
3
9
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
7
1
1
8</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>succinate
dehydrogenase
complex iron
sulfur
subunit B</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id205"><span class="problematic" id="id206">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hereditary
Paragangl
ioma-Pheochromocytoma
Syndromes;
Carney-Stratakis
syndrome</p></td>
</tr>
<tr class="row-even"><td><p>3
4
5</p></td>
<td><p>SDHC</p></td>
<td><p>6
3
9
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
3
2
5
2</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>succinate
dehydrogenase
complex
subunit C</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id207"><span class="problematic" id="id208">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hereditary
Paragangl
ioma-Pheochromocytoma
Syndromes;
Carney-Stratakis
syndrome</p></td>
</tr>
<tr class="row-odd"><td><p>3
4
6</p></td>
<td><p>SDHD</p></td>
<td><p>6
3
9
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
0
4
3
7
0</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>succinate
dehydrogenase
complex
subunit D</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id209"><span class="problematic" id="id210">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hereditary
Paragangl
ioma-Pheochromocytoma
Syndromes;
Carney-Stratakis
syndrome</p></td>
</tr>
<tr class="row-even"><td><p>3
4
7</p></td>
<td><p>SEC23B</p></td>
<td><p>1
0
4
8
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
1
3
1
0</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>SEC23 homolog
B, COPII coat
complex
component</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
4
8</p></td>
<td><p>SEMA4A</p></td>
<td><p>6
4
2
1
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
9
6
1
8
9</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>semaphorin 4A</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
4
9</p></td>
<td><p>SERPINA1</p></td>
<td><p>5
2
6
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
9
7
2
4
9</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>serpin family
A member 1</p></td>
<td><p>OT
HER,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Alpha-1-antitrypsin
deficiency</p></td>
</tr>
<tr class="row-odd"><td><p>3
5
0</p></td>
<td><p>SETBP1</p></td>
<td><p>2
6
0
4
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
5
2
2
1
7</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>SET binding
protein 1</p></td>
<td><p>CGC
_94,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Schinzel-Giedion
syndrome</p></td>
</tr>
<tr class="row-even"><td><p>3
5
1</p></td>
<td><p>SETMAR</p></td>
<td><p>6
4
1
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
0
3
6
4</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>SET domain
and mariner
transposase
fusion gene</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
5
2</p></td>
<td><p>SFTPA1</p></td>
<td><p>6
5
3
5
0
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
2
8
5
2</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>surfactant
protein A1</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
5
3</p></td>
<td><p>SFTPA2</p></td>
<td><p>7
2
9
2
3
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
5
3
0
3</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>surfactant
protein A2</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
5
4</p></td>
<td><p>SH2B3</p></td>
<td><p>1
0
0
1
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
1
2
5
2</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>SH2B adaptor
protein 3</p></td>
<td><p>P
<a href="#id211"><span class="problematic" id="id212">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
5
5</p></td>
<td><p>SH2D1A</p></td>
<td><p>4
0
6
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
3
9
1
8</p></td>
<td><p>N
A</p></td>
<td><p>L
o
F</p></td>
<td><p>SH2 domain
containing 1A</p></td>
<td><p>P
<a href="#id213"><span class="problematic" id="id214">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
5
6</p></td>
<td><p>SHOC2</p></td>
<td><p>8
0
3
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
8
0
6
1</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>SHOC2 leucine
rich repeat
scaffold
protein</p></td>
<td><p>P
<a href="#id215"><span class="problematic" id="id216">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Noonan syndrome-like
disorder with loose
anagen hair</p></td>
</tr>
<tr class="row-even"><td><p>3
5
7</p></td>
<td><p>SIX1</p></td>
<td><p>6
4
9
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
6
7
7
8</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>SIX homeobox
1</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
5
8</p></td>
<td><p>SLC25A13</p></td>
<td><p>1
0
1
6
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
0
4
8
6
4</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>solute
carrier
family 25
member 13</p></td>
<td><p>T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
5
9</p></td>
<td><p>SLC26A3</p></td>
<td><p>1
8
1
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
9
1
1
3
8</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>solute
carrier
family 26
member 3</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
6
0</p></td>
<td><p>SLC5A5</p></td>
<td><p>6
5
2
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
5
6
4
1</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>solute
carrier
family 5
member 5</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
6
1</p></td>
<td><p>SLX4</p></td>
<td><p>8
4
4
6
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
8
8
2
7</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>SLX4
struc
ture-specific
endonuclease
subunit</p></td>
<td><p>NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
6
2</p></td>
<td><p>SMAD4</p></td>
<td><p>4
0
8
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
1
6
4
6</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>SMAD family
member 4</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id217"><span class="problematic" id="id218">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hereditary
hemorrhagic
telangiectasia;
Juvenile polyposis
syndrome</p></td>
</tr>
<tr class="row-even"><td><p>3
6
3</p></td>
<td><p>SMAD9</p></td>
<td><p>4
0
9
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
0
6
9
3</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>SMAD family
member 9</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
6
4</p></td>
<td><p>SMARCA2</p></td>
<td><p>6
5
9
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
8
0
5
0
3</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>SWI/SNF
related,
matrix
associated,
actin
dependent
regulator of
chromatin,
subfamily a,
member 2</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
6
5</p></td>
<td><p>SMARCA4</p></td>
<td><p>6
5
9
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
7
6
1
6</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>SWI/SNF
related,
matrix
associated,
actin
dependent
regulator of
chromatin,
subfamily a,
member 4</p></td>
<td><p>N
CGC,P
<a href="#id219"><span class="problematic" id="id220">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Rhabdoid tumor
predisposition
syndrome 2</p></td>
</tr>
<tr class="row-odd"><td><p>3
6
6</p></td>
<td><p>SMARCB1</p></td>
<td><p>6
5
9
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
9
9
9
5
6</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>SWI/SNF
related,
matrix
associated,
actin
dependent
regulator of
chromatin,
subfamily b,
member 1</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id221"><span class="problematic" id="id222">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Rhabdoid tumor
predisposition
syndrome 1</p></td>
</tr>
<tr class="row-even"><td><p>3
6
7</p></td>
<td><p>SMARCE1</p></td>
<td><p>6
6
0
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
7
3
5
8
4</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>SWI/SNF
related,
matrix
associated,
actin
dependent
regulator of
chromatin,
subfamily e,
member 1</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id223"><span class="problematic" id="id224">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hereditary Meningioma</p></td>
</tr>
<tr class="row-odd"><td><p>3
6
8</p></td>
<td><p>SMO</p></td>
<td><p>6
6
0
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
8
6
0
2</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>smoothened,
frizzled
class
receptor</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
6
9</p></td>
<td><p>SOCS1</p></td>
<td><p>8
6
5
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
5
3
3
8</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>suppressor of
cytokine
signaling 1</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
7
0</p></td>
<td><p>SOS1</p></td>
<td><p>6
6
5
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
5
9
0
4</p></td>
<td><p>A
D</p></td>
<td><p>G
o
F</p></td>
<td><p>SOS Ras/Rac
guanine
nucleotide
exchange
factor 1</p></td>
<td><p>P
<a href="#id225"><span class="problematic" id="id226">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Noonan syndrome</p></td>
</tr>
<tr class="row-even"><td><p>3
7
1</p></td>
<td><p>SOS2</p></td>
<td><p>6
6
5
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
0
4
8
5</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>SOS Ras/Rho
guanine
nucleotide
exchange
factor 2</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
7
2</p></td>
<td><p>SPINK1</p></td>
<td><p>6
6
9
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
4
2
6
6</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>serine
peptidase
inhibitor
Kazal type 1</p></td>
<td><p>NCGC</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
7
3</p></td>
<td><p>SPOP</p></td>
<td><p>8
4
0
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
1
0
6
7</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>speckle type
BTB/POZ
protein</p></td>
<td><p>C
GC_94
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
7
4</p></td>
<td><p>SPRED1</p></td>
<td><p>1
6
1
7
4
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
6
0
6
8</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>sprouty
related EVH1
domain
containing 1</p></td>
<td><p>NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
7
5</p></td>
<td><p>SPRTN</p></td>
<td><p>8
3
9
3
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
1
0
0
7
2</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>SprT-like
N-terminal
domain</p></td>
<td><p>T
CGA_P
ANCAN
_2018</p></td>
<td><p>Ruijs-Aalfs syndrome</p></td>
</tr>
<tr class="row-odd"><td><p>3
7
6</p></td>
<td><p>SQSTM1</p></td>
<td><p>8
8
7
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
1
0
1
1</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>sequestosome
1</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
7
7</p></td>
<td><p>SRC</p></td>
<td><p>6
7
1
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
9
7
1
2
2</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>SRC
pr
oto-oncogene,
non-receptor
tyrosine
kinase</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
7
8</p></td>
<td><p>SRGAP1</p></td>
<td><p>5
7
5
2
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
9
6
9
3
5</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>SLIT-ROBO Rho
GTPase
activating
protein 1</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
7
9</p></td>
<td><p>SRP72</p></td>
<td><p>6
7
3
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
4
7
8
0</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>signal
recognition
particle 72</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
8
0</p></td>
<td><p>SRRM2</p></td>
<td><p>2
3
5
2
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
7
9
7
8</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>se
rine/arginine
repetitive
matrix 2</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
8
1</p></td>
<td><p>SRY</p></td>
<td><p>6
7
3
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
4
8
9
5</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>sex
determining
region Y</p></td>
<td><p>T
CGA_P
ANCAN
_2018</p></td>
<td><p>Gonadoblastoma</p></td>
</tr>
<tr class="row-odd"><td><p>3
8
2</p></td>
<td><p>STAT3</p></td>
<td><p>6
7
7
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
8
6
1
0</p></td>
<td><p>A
D</p></td>
<td><p>L
o
F</p></td>
<td><p>signal
transducer
and activator
of
transcription
3</p></td>
<td><p>CGC
_94,P
<a href="#id227"><span class="problematic" id="id228">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>STAT3 Deficiency</p></td>
</tr>
<tr class="row-even"><td><p>3
8
3</p></td>
<td><p>STK11</p></td>
<td><p>6
7
9
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
8
0
4
6</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>ser
ine/threonine
kinase 11</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id229"><span class="problematic" id="id230">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Peutz-Jeghers
syndrome</p></td>
</tr>
<tr class="row-odd"><td><p>3
8
4</p></td>
<td><p>STN1</p></td>
<td><p>7
9
9
9
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
7
9
6
0</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>STN1 subunit
of CST
complex</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
8
5</p></td>
<td><p>STX11</p></td>
<td><p>8
6
7
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
5
6
0
4</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>syntaxin 11</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
8
6</p></td>
<td><p>STXBP2</p></td>
<td><p>6
8
1
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
7
6
9
4
4</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>syntaxin
binding
protein 2</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
8
7</p></td>
<td><p>SUFU</p></td>
<td><p>5
1
6
8
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
7
8
8
2</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>SUFU negative
regulator of
hedgehog
signaling</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id231"><span class="problematic" id="id232">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Medulloblastoma;
Hereditary Meningioma</p></td>
</tr>
<tr class="row-odd"><td><p>3
8
8</p></td>
<td><p>SYK</p></td>
<td><p>6
8
5
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
5
0
2
5</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>spleen
associated
tyrosine
kinase</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
8
9</p></td>
<td><p>TBXT</p></td>
<td><p>6
8
6
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
4
4
5
8</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>T-box
transcription
factor T</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
9
0</p></td>
<td><p>TCF7L2</p></td>
<td><p>6
9
3
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
8
7
3
7</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>transcription
factor 7 like
2</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
9
1</p></td>
<td><p>TERC</p></td>
<td><p>7
0
1
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
7
7
9
2
5</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>telomerase
RNA component</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
9
2</p></td>
<td><p>TERF2IP</p></td>
<td><p>5
4
3
8
6</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>TERF2
interacting
protein</p></td>
<td><p>NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
9
3</p></td>
<td><p>TERT</p></td>
<td><p>7
0
1
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
4
3
6
2</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>telomerase
reverse
transcriptase</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id233"><span class="problematic" id="id234">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Autosomal dominant
dyskeratosis
congenita</p></td>
</tr>
<tr class="row-odd"><td><p>3
9
4</p></td>
<td><p>TET2</p></td>
<td><p>5
4
7
9
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
8
7
6
9</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>tet
m
ethylcytosine
dioxygenase 2</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
9
5</p></td>
<td><p>TFAP2A</p></td>
<td><p>7
0
2
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
7
2
0
3</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>transcription
factor AP-2
alpha</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
9
6</p></td>
<td><p>TFE3</p></td>
<td><p>7
0
3
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
6
8
3
2
3</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>transcription
factor
binding to
IGHM enhancer
3</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>3
9
7</p></td>
<td><p>TG</p></td>
<td><p>7
0
3
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
4
2
8
3
2</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>thyroglobulin</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>3
9
8</p></td>
<td><p>TGFBR1</p></td>
<td><p>7
0
4
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
6
7
9
9</p></td>
<td><p>A
D</p></td>
<td><p>L
o
F</p></td>
<td><p>transforming
growth factor
beta receptor
1</p></td>
<td><p>A
CMG_S
F30,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Multiple self-healing
squamous epithelioma;
Loeys-Dietz syndrome</p></td>
</tr>
<tr class="row-even"><td><p>3
9
9</p></td>
<td><p>TGFBR2</p></td>
<td><p>7
0
4
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
3
5
1
3</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>transforming
growth factor
beta receptor
2</p></td>
<td><p>A
CMG_S
F30,C
GC_94</p></td>
<td><p>Loeys-Dietz syndrome</p></td>
</tr>
<tr class="row-odd"><td><p>4
0
0</p></td>
<td><p>TINF2</p></td>
<td><p>2
6
2
7
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
9
2
3
3
0</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>TERF1
interacting
nuclear
factor 2</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>4
0
1</p></td>
<td><p>TMC6</p></td>
<td><p>1
1
3
2
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
1
5
2
4</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>transmembrane
channel like
6</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>4
0
2</p></td>
<td><p>TMC8</p></td>
<td><p>1
4
7
1
3
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
7
8
9
5</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>transmembrane
channel like
8</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>4
0
3</p></td>
<td><p>TMEM127</p></td>
<td><p>5
5
6
5
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
5
9
5
6</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>transmembrane
protein 127</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id235"><span class="problematic" id="id236">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Pheochromocytoma;
Hereditary
Paragangl
ioma-Pheochromocytoma
Syndromes</p></td>
</tr>
<tr class="row-odd"><td><p>4
0
4</p></td>
<td><p>TNFAIP3</p></td>
<td><p>7
1
2
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
8
5
0
3</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>TNF alpha
induced
protein 3</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>4
0
5</p></td>
<td><p>TNFRSF11A</p></td>
<td><p>8
7
9
2</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
1
6
5
5</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>TNF receptor
superfamily
member 11a</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>4
0
6</p></td>
<td><p>TP53</p></td>
<td><p>7
1
5
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
1
5
1
0</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>tumor protein
p53</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id237"><span class="problematic" id="id238">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA; Li-Fraumeni
syndrome 1</p></td>
</tr>
<tr class="row-even"><td><p>4
0
7</p></td>
<td><p>TP63</p></td>
<td><p>8
6
2
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
7
3
2
8
2</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>tumor protein
p63</p></td>
<td><p>C
GC_94</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>4
0
8</p></td>
<td><p>TRIM24</p></td>
<td><p>8
8
0
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
2
7
7
9</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>tripartite
motif
containing 24</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>4
0
9</p></td>
<td><p>TRIM28</p></td>
<td><p>1
0
1
5
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
0
7
2
6</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>tripartite
motif
containing 28</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>4
1
0</p></td>
<td><p>TRIM37</p></td>
<td><p>4
5
9
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
8
3
9
5</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>tripartite
motif
containing 37</p></td>
<td><p>P
<a href="#id239"><span class="problematic" id="id240">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>4
1
1</p></td>
<td><p>TRIP13</p></td>
<td><p>9
3
1
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
7
1
5
3
9</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>thyroid
hormone
receptor
interactor 13</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>4
1
2</p></td>
<td><p>TSC1</p></td>
<td><p>7
2
4
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
5
6
9
9</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>TSC complex
subunit 1</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id241"><span class="problematic" id="id242">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Tuberous sclerosis
syndrome; Tuberous
sclerosis 1</p></td>
</tr>
<tr class="row-even"><td><p>4
1
3</p></td>
<td><p>TSC2</p></td>
<td><p>7
2
4
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
3
1
9
7</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>TSC complex
subunit 2</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id243"><span class="problematic" id="id244">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Tuberous sclerosis
syndrome; Tuberous
sclerosis 2</p></td>
</tr>
<tr class="row-odd"><td><p>4
1
4</p></td>
<td><p>TSHR</p></td>
<td><p>7
2
5
3</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
5
4
0
9</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>thyroid
stimulating
hormone
receptor</p></td>
<td><p>CGC
_94,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Hyperthyroidism,
nonautoimmune</p></td>
</tr>
<tr class="row-even"><td><p>4
1
5</p></td>
<td><p>TSR2</p></td>
<td><p>9
0
1
2
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
5
8
5
2
6</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>TSR2 ribosome
maturation
factor</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>4
1
6</p></td>
<td><p>TYK2</p></td>
<td><p>7
2
9
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
5
3
9
7</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>tyrosine
kinase 2</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>4
1
7</p></td>
<td><p>UBE2T</p></td>
<td><p>2
9
0
8
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
7
7
1
5
2</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>ubiquitin
conjugating
enzyme E2 T</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>4
1
8</p></td>
<td><p>UNC13D</p></td>
<td><p>2
0
1
2
9
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
9
2
9
2
9</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>N
A</p></td>
<td><p>unc-13
homolog D</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>4
1
9</p></td>
<td><p>UROD</p></td>
<td><p>7
3
8
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
6
0
8
8</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>uro
porphyrinogen
decarboxylase</p></td>
<td><p>T
CGA_P
ANCAN
_2018</p></td>
<td><p>Familial porphyria
cutanea tarda</p></td>
</tr>
<tr class="row-odd"><td><p>4
2
0</p></td>
<td><p>VANGL1</p></td>
<td><p>8
1
8
3
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
7
3
2
1
8</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>VANGL planar
cell polarity
protein 1</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>4
2
1</p></td>
<td><p>VDR</p></td>
<td><p>7
4
2
1</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
1
1
4
2
4</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>N
A</p></td>
<td><p>vitamin D
receptor</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>4
2
2</p></td>
<td><p>VHL</p></td>
<td><p>7
4
2
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
4
0
8
6</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>von
Hippel-Lindau
tumor
suppressor</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id245"><span class="problematic" id="id246">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Von Hippel-Lindau
syndrome</p></td>
</tr>
<tr class="row-even"><td><p>4
2
3</p></td>
<td><p>VTRNA2-1</p></td>
<td><p>1
0
0
1
2
6
2
9
9</p></td>
<td><p>E
N
S
G
0
0
0
0
0
2
7
8
8
1
5</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>vault RNA 2-1</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>4
2
4</p></td>
<td><p>WAS</p></td>
<td><p>7
4
5
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
0
1
5
2
8
5</p></td>
<td><p>N
A</p></td>
<td><p>L
o
F</p></td>
<td><p>WASP actin
nucleation
promoting
factor</p></td>
<td><p>CGC
_94,P
<a href="#id247"><span class="problematic" id="id248">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Thrombocytopenia 1</p></td>
</tr>
<tr class="row-even"><td><p>4
2
5</p></td>
<td><p>WIF1</p></td>
<td><p>1
1
1
9
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
5
6
0
7
6</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>WNT
inhibitory
factor 1</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>4
2
6</p></td>
<td><p>WRAP53</p></td>
<td><p>5
5
1
3
5</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
4
1
4
9
9</p></td>
<td><p>A
R</p></td>
<td><p>N
A</p></td>
<td><p>WD repeat
containing
antisense to
TP53</p></td>
<td><p>PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>4
2
7</p></td>
<td><p>WRN</p></td>
<td><p>7
4
8
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
6
5
3
9
2</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>WRN RecQ like
helicase</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id249"><span class="problematic" id="id250">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Werner syndrome</p></td>
</tr>
<tr class="row-odd"><td><p>4
2
8</p></td>
<td><p>WT1</p></td>
<td><p>7
4
9
0</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
8
4
9
3
7</p></td>
<td><p>A
D
/
A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>WT1
transcription
factor</p></td>
<td><p>ACM
G_SF3
0,CGC
_94,N
CGC,P
<a href="#id251"><span class="problematic" id="id252">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Wilms tumor 1</p></td>
</tr>
<tr class="row-even"><td><p>4
2
9</p></td>
<td><p>XPA</p></td>
<td><p>7
5
0
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
3
6
9
3
6</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>XPA, DNA
damage
recognition
and repair
factor</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id253"><span class="problematic" id="id254">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Xeroderma pigmentosum
group A</p></td>
</tr>
<tr class="row-odd"><td><p>4
3
0</p></td>
<td><p>XPC</p></td>
<td><p>7
5
0
8</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
5
4
7
6
7</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>XPC complex
subunit, DNA
damage
recognition
and repair
factor</p></td>
<td><p>CGC
_94,N
CGC,P
<a href="#id255"><span class="problematic" id="id256">ANEL_</span></a>
APP,T
CGA_P
ANCAN
_2018</p></td>
<td><p>Xeroderma
pigmentosum, group C</p></td>
</tr>
<tr class="row-even"><td><p>4
3
1</p></td>
<td><p>XRCC2</p></td>
<td><p>7
5
1
6</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
9
6
5
8
4</p></td>
<td><p>A
R</p></td>
<td><p>L
o
F</p></td>
<td><p>X-ray repair
cross
complementing
2</p></td>
<td><p>NCGC
,PANE
L_APP</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-odd"><td><p>4
3
2</p></td>
<td><p>XRCC3</p></td>
<td><p>7
5
1
7</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
2
6
2
1
5</p></td>
<td><p>A
D</p></td>
<td><p>N
A</p></td>
<td><p>X-ray repair
cross
complementing
3</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
<tr class="row-even"><td><p>4
3
3</p></td>
<td><p>ZBTB16</p></td>
<td><p>7
7
0
4</p></td>
<td><p>E
N
S
G
0
0
0
0
0
1
0
9
9
0
6</p></td>
<td><p>N
A</p></td>
<td><p>N
A</p></td>
<td><p>zinc finger
and BTB
domain
containing 16</p></td>
<td><p>OTHER</p></td>
<td><p>NA</p></td>
</tr>
</tbody>
</table>
</div>


           </div>
           
          </div>
          <footer>
  
    <div class="rst-footer-buttons" role="navigation" aria-label="footer navigation">
      
        <a href="input.html" class="btn btn-neutral float-right" title="Input" accesskey="n" rel="next">Next <span class="fa fa-arrow-circle-right"></span></a>
      
      
        <a href="annotation_resources.html" class="btn btn-neutral float-left" title="CPSR annotation resources" accesskey="p" rel="prev"><span class="fa fa-arrow-circle-left"></span> Previous</a>
      
    </div>
  

  <hr/>

  <div role="contentinfo">
    <p>
        &copy; Copyright 2018-2021, Sigve Nakken

    </p>
  </div>
  Built with <a href="http://sphinx-doc.org/">Sphinx</a> using a <a href="https://github.com/rtfd/sphinx_rtd_theme">theme</a> provided by <a href="https://readthedocs.org">Read the Docs</a>. 

</footer>

        </div>
      </div>

    </section>

  </div>
  


  <script type="text/javascript">
      jQuery(function () {
          SphinxRtdTheme.Navigation.enable(true);
      });
  </script>

  
  
    
    

  <style>
    /* Sidebar header (and topbar for mobile) */
    .wy-side-nav-search, .wy-nav-top {
      background: #0B6121;
    }
    /* Sidebar */
    /*.wy-nav-side {*/
    /*  background: #ff0000;*/
    /*}*/
  </style>


</body>
</html>